Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2016 | Mar. 27, 2017 | Jun. 30, 2016 | |
Document Information [Line Items] | |||
Entity Registrant Name | OMNICOMM SYSTEMS INC | ||
Entity Central Index Key | 1,034,592 | ||
Trading Symbol | omcm | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Common Stock, Shares Outstanding (in shares) | 147,770,249 | ||
Entity Public Float | $ 19,500,958 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2016 | ||
Document Fiscal Year Focus | 2,016 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
CURRENT ASSETS | ||
Cash | $ 1,439,332 | $ 835,219 |
Accounts receivable, net of allowance for doubtful accounts of $179,813 and $116,834, respectively | 5,455,210 | 4,092,472 |
Prepaid expenses | 195,915 | 170,173 |
Prepaid stock compensation, current portion | 148,422 | 175,858 |
Other current assets | 35,055 | 14,351 |
Total current assets | 7,273,934 | 5,288,073 |
Property and equipment, net | 637,552 | 683,712 |
Intangible assets, net | 108,880 | 148,877 |
Prepaid stock compensation | 58,663 | 150,085 |
Other assets | 51,321 | 46,565 |
TOTAL ASSETS | 8,130,350 | 6,317,312 |
CURRENT LIABILITIES | ||
Accounts payable and accrued expenses | 2,123,073 | 1,957,270 |
Deferred revenue, current portion | 7,250,061 | 7,054,614 |
Convertible notes payable, current portion | 50,000 | 75,000 |
Conversion feature liability, related parties | 1,479,748 | 561,137 |
Total current liabilities | 16,610,726 | 12,865,550 |
LONG TERM LIABILITIES | ||
Line of credit, long term | 2,700,000 | 4,200,000 |
Notes payable, related parties, long term, net of current portion, net of discount of $237,664 and $-0-, respectively | 212,336 | 20,000 |
Notes payable, long term, net of current portion, net of discount of $455,285 and $-0-, respectively | 337,215 | 792,500 |
Deferred revenue, long term, net of current portion | 2,289,169 | 2,193,163 |
Convertible notes payable, related parties, long term, net of current portion | 5,825,000 | 5,850,000 |
Convertible notes payable, long term, net of current portion | 1,175,000 | 1,350,000 |
Patent settlement liability, long term, net of current portion | 108,702 | 464,573 |
TOTAL LIABILITIES | 29,258,148 | 27,735,786 |
COMMITMENTS AND CONTINGENCIES (See Note 10) | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 0 | 0 |
Common stock, 500,000,000 shares authorized, 147,786,917 and 131,703,577 issued and outstanding, respectively, at $0.001 par value | 147,788 | 131,704 |
Additional paid in capital - preferred | 999,750 | 4,230,792 |
Additional paid in capital - common | 53,425,956 | 49,974,415 |
Accumulated other comprehensive (loss) | (410,505) | (366,355) |
Accumulated (deficit) | (75,291,037) | (75,392,917) |
TOTAL SHAREHOLDERS' (DEFICIT) | (21,127,798) | (21,418,474) |
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT) | 8,130,350 | 6,317,312 |
Series B Preferred Stock [Member] | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 0 | 0 |
Series C Preferred Stock [Member] | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 0 | 0 |
Series A Preferred Stock [Member] | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 0 | 3,637 |
TOTAL SHAREHOLDERS' (DEFICIT) | 0 | 3,637 |
Series D Preferred Stock [Member] | ||
SHAREHOLDERS' (DEFICIT) | ||
Preferred stock | 250 | 250 |
TOTAL SHAREHOLDERS' (DEFICIT) | 250 | 250 |
Conversion Feature Liability Related Parties [Member] | ||
CURRENT LIABILITIES | ||
Patent settlement liability, current portion | 862,500 | 962,500 |
Conversion Feature Liability [Member] | ||
CURRENT LIABILITIES | ||
Conversion feature liability, related parties | 1,740,278 | 535,835 |
Warrant Liability Related Parties [Member] | ||
CURRENT LIABILITIES | ||
Conversion feature liability, related parties | 585,452 | 365,408 |
Warrant Liability [Member] | ||
CURRENT LIABILITIES | ||
Conversion feature liability, related parties | $ 2,519,614 | $ 1,353,786 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
Allowance for doubtful accounts | $ 179,813 | $ 116,834 |
Notes payable discount | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, shares undesignated | $ 3,772,500 | $ 3,772,500 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 147,786,917 | 131,703,577 |
Common stock, shares outstanding (in shares) | 147,786,917 | 131,703,577 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Series B Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 230,000 | 230,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Preferred stock, liquidation preference | $ 0 | $ 0 |
Series C Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 747,500 | 747,500 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Preferred stock, liquidation preference | $ 0 | $ 0 |
Series A Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, shares issued (in shares) | 0 | 3,637,724 |
Preferred stock, shares outstanding (in shares) | 0 | 3,637,724 |
Preferred stock, liquidation preference | $ 0 | $ 3,637,724 |
Series D Preferred Stock [Member] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 250,000 | 250,000 |
Preferred stock, shares issued (in shares) | 250,000 | 250,000 |
Preferred stock, shares outstanding (in shares) | 250,000 | 250,000 |
Related Party Long Term [Member] | ||
Notes payable discount | $ 237,664 | $ 0 |
Notes Payable, Other Payables [Member] | ||
Notes payable discount | $ 455,285 | $ 0 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Revenues | $ 24,394,010 | $ 20,023,733 |
Reimbursable revenues | 1,025,500 | 687,104 |
Total revenues | 25,419,510 | 20,710,837 |
Cost of goods sold | 3,913,407 | 3,770,013 |
Reimbursable expenses-cost of goods sold | 1,461,425 | 677,568 |
Total cost of goods sold | 5,374,832 | 4,447,581 |
Gross margin | 20,044,678 | 16,263,256 |
Operating expenses | ||
Salaries, benefits and related taxes | 11,383,727 | 10,602,686 |
Rent and occupancy expenses | 1,071,363 | 972,862 |
Consulting services | 185,340 | 253,626 |
Legal and professional fees | 364,859 | 415,834 |
Travel | 774,379 | 779,817 |
Telephone and internet | 164,014 | 166,361 |
Selling, general and administrative | 1,462,774 | 1,530,765 |
Bad debt expense | 132,767 | 14,939 |
Depreciation expense | 302,893 | 233,798 |
Amortization expense | 37,331 | 40,338 |
Total operating expenses | 15,879,447 | 15,011,026 |
Operating income/(loss) | 4,165,231 | 1,252,230 |
Other income/(expense) | ||
Interest expense, related parties | (918,189) | (2,434,101) |
Interest expense | (421,713) | (299,668) |
Interest income | 2 | 4 |
Change in derivative liabilities | (2,657,910) | 4,525,798 |
Impairment of goodwill | 0 | (536,285) |
Other income | 0 | 124,373 |
Transaction gain/(loss) | (64,472) | (70,706) |
Income/(loss) before income taxes | 102,949 | 2,561,645 |
Income tax (expense) | (1,069) | 24,739 |
Net income/(loss) | 101,880 | 2,586,384 |
Preferred stock dividends | ||
Series A preferred | 0 | (181,886) |
Net income/(loss) attributable to common stockholders | $ 101,880 | $ 2,404,498 |
Net income/(loss) per share | ||
Basic (in dollars per share) | $ 0 | $ 0.02 |
Diluted (in dollars per share) | $ 0 | $ 0.02 |
Weighted average number of shares outstanding | ||
Basic (in shares) | 145,868,227 | 96,645,482 |
Diluted (in shares) | 146,162,427 | 113,545,741 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income/(Loss) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Net income/(loss) attributable to common stockholders | $ 101,880 | $ 2,404,498 |
Other comprehensive income/(loss) | ||
Change in foreign currency translation adjustment | (44,150) | (122,528) |
Other comprehensive income/(loss) | (44,150) | (122,528) |
Comprehensive income/(loss) | $ 57,730 | $ 2,281,970 |
Consolidated Statement of Share
Consolidated Statement of Shareholders' (Deficit) - USD ($) | Series A Preferred Stock [Member] | Series D Preferred Stock [Member] | Additional Paid In Capital Preferred [Member] | Common Stock [Member] | Additional Paid In Capital Common [Member] | Retained Earnings [Member] | AOCI Attributable to Parent [Member] | Total |
Balance (in shares) at Dec. 31, 2014 | 4,125,224 | 250,000 | 91,561,802 | |||||
Balance at Dec. 31, 2014 | $ 4,125 | $ 250 | $ 4,717,804 | $ 91,562 | $ 37,634,555 | $ (77,979,301) | $ (243,827) | $ (35,774,832) |
Employee stock option expense | 43,090 | 43,090 | ||||||
Change in foreign currency translation adjustment | (122,528) | (122,528) | ||||||
Restricted stock issuance/(forfeiture) (in shares) | 908,330 | |||||||
Restricted stock issuance/(forfeiture) | $ 908 | 226,875 | $ 227,783 | |||||
Issuance of common stock, stock option exercise (in shares) | 252,500 | 292,500 | ||||||
Issuance of common stock, stock option exercise | $ 253 | 26,997 | $ 27,250 | |||||
Cashless issuance of common stock, stock option exercise (in shares) | 7,428 | |||||||
Cashless issuance of common stock, stock option exercise | $ 7 | (7) | 0 | |||||
Issuance of common stock, in exchange for Series A Preferred Stock (in shares) | (487,500) | 1,950,000 | ||||||
Issuance of common stock, in exchange for Series A Preferred Stock | $ (488) | (487,012) | $ 1,950 | 485,550 | 0 | |||
Issuance of common stock in exchange for converted and cancelled debt and cancelled warrants (in shares) | 37,023,517 | |||||||
Issuance of common stock in exchange for converted and cancelled debt and cancelled warrants | $ 37,024 | 11,557,355 | 11,594,379 | |||||
Net income/(loss) | $ 0 | $ 0 | 0 | $ 0 | 0 | 2,586,384 | 0 | 2,586,384 |
Balance (in shares) at Dec. 31, 2015 | 3,637,724 | 250,000 | 131,703,577 | |||||
Balance at Dec. 31, 2015 | $ 3,637 | $ 250 | 4,230,792 | $ 131,704 | 49,974,415 | (75,392,917) | (366,355) | (21,418,474) |
Employee stock option expense | 35,046 | 35,046 | ||||||
Change in foreign currency translation adjustment | (44,150) | (44,150) | ||||||
Restricted stock issuance/(forfeiture) (in shares) | 360,000 | |||||||
Restricted stock issuance/(forfeiture) | $ 360 | 68,040 | $ 68,400 | |||||
Issuance of common stock, stock option exercise (in shares) | 1,100,000 | 1,120,000 | ||||||
Issuance of common stock, stock option exercise | $ 1,100 | 128,400 | $ 129,500 | |||||
Cashless issuance of common stock, stock option exercise (in shares) | 7,644 | |||||||
Cashless issuance of common stock, stock option exercise | $ 8 | (8) | 0 | |||||
Issuance of common stock, in exchange for Series A Preferred Stock (in shares) | (3,637,724) | 14,615,696 | ||||||
Issuance of common stock, in exchange for Series A Preferred Stock | $ (3,637) | (3,231,042) | $ 14,616 | 3,220,063 | 0 | |||
Net income/(loss) | $ 0 | $ 0 | 0 | $ 0 | 0 | 101,880 | 0 | 101,880 |
Balance (in shares) at Dec. 31, 2016 | 0 | 250,000 | 147,786,917 | |||||
Balance at Dec. 31, 2016 | $ 0 | $ 250 | $ 999,750 | $ 147,788 | $ 53,425,956 | $ (75,291,037) | $ (410,505) | $ (21,127,798) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net income/(loss) | $ 101,880 | $ 2,586,384 |
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities | ||
Change in derivative liabilities | 2,657,910 | (4,525,798) |
Impairment of goodwill | 0 | 536,285 |
Interest expense from derivative instruments | 158,068 | 611,089 |
Employee stock compensation | 222,304 | 245,083 |
Provision for doubtful accounts | 132,767 | 14,939 |
Depreciation and amortization | 340,224 | 274,136 |
Changes in operating assets and liabilities | ||
Accounts receivable | (1,495,505) | (691,260) |
Prepaid expenses | (25,742) | 57,909 |
Other current assets | (20,704) | 3,954 |
Other assets | (4,756) | 2,527 |
Accounts payable and accrued expenses | 615,803 | 733,085 |
Patent settlement liability | (455,871) | (205,252) |
Deferred revenue | 291,453 | 1,013,834 |
Net cash provided by/(used in) operating activities | 2,517,831 | 656,915 |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Purchase of property and equipment | (260,378) | (450,707) |
Net cash (used in) investing activities | (260,378) | (450,707) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Repayments of notes payable | (245,000) | (75,000) |
Proceeds/(repayments) from revolving line of credit | (1,500,000) | 200,000 |
Proceeds from Stock Options Exercised | 129,500 | 27,250 |
Net cash provided by/(used in) financing activities | (1,615,500) | 152,250 |
Effect of exchange rate changes on fixed and intangible assets | 6,310 | 76,375 |
Effect of exchange rate changes on cash and cash equivalents | (44,150) | (122,528) |
Net increase/(decrease) in cash and cash equivalents | 604,113 | 312,305 |
Cash and cash equivalents at beginning of period | 835,219 | 522,914 |
Cash and cash equivalents at end of period | 1,439,332 | 835,219 |
Supplemental disclosures of cash flow information: | ||
Income taxes | 1,069 | (24,739) |
Interest | 1,445,684 | 1,457,028 |
Non-cash transactions: | ||
Restricted stock issuance/(forfeiture) | 68,400 | 227,783 |
Common stock issued in exchange for 5% Series A Preferred Stock | 3,637,724 | 487,500 |
Notes payable and warrants cancelled in exchange for common stock | 0 | 7,339,000 |
Notes payable converted into common stock | 0 | 1,915,000 |
Promasys B.V. [Member] | ||
Non-cash transactions: | ||
Promissory notes issued for accrued interest | 450,000 | 670,000 |
Notes Payable Issued For Existing Notes Payable [Member] | ||
Non-cash transactions: | ||
Debt Conversion, Original Debt, Amount | $ 7,652,500 | $ 20,193,000 |
Note 1 - Organization and Natur
Note 1 - Organization and Nature of Operations | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Nature of Operations [Text Block] | NOTE 1: ORGANIZATION AND NATURE OF OPERATIONS OmniComm Systems, Inc. (“OmniComm” or the “Company”) is a healthcare te chnology company that provides web-based electronic data capture (“EDC”) solutions and related value-added services to pharmaceutical and biotechnology companies, clinical research organizations(“CROs”), and other clinical trial sponsors principally located in the United States, Europe and East Asia. Our proprietary EDC software applications; TrialMaster ® ; TrialOne ® ; Promasys ® ; and eClinical Suite, allow clinical trial sponsors and investigative sites to securely collect, validate, transmit, and analyze clinical trial data. Our ability to compete within the EDC industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through our EDC software and services. Our efforts are focused on developing new and complementary software solutions, as well as enhancing our existing software solutions, through the addition of increased functionality. During the years ended December 31, 2016 December 31, 2015 $2,598,962 $2,639,577, activities, which is primarily comprised of salaries to our developers and other personnel and related costs associated with the development of our software products |
Note 2 - Summary of Significant
Note 2 - Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company ’s accounts include those of all its wholly-owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation. ESTIMATES IN FINANCIAL STATEMENTS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may RECLASSIFICATIONS Certain reclassifications have been made in the 2015 2016 FOREIGN CURRENCY TRANSLATION The financial statements of the Company ’s foreign subsidiaries are translated in accordance with ASC 830 30, Foreign Currency Matters—Translation of Financial Statements $44,150 December 31, 2016 $122,528 December 31, 2015. REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne , Promasys eClinical Suite ( “EDC Software”). TrialMaster eClinical Suite The Company recognizes revenues when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) (3) (4) The Company operates in one The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four Hosted Application Revenues The Company offers its TrialMaster eClinical Suite Revenues resulting from TrialMaster eClinical Suite three first second third Fees charged and costs incurred for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second eClinical Suite Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC Software products with its customers for 3 5 30 45 In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may The Company generates customer support and maintenance revenues from its perpetual license customer base. Professional Services The Company may Subsequent additions or extensions to license terms do not generally include additional professional services. Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the years ended December 31, 2016 December 31, 2015, For the year ended Revenue activity December 31, 2016 December 31, 2015 Set-up fees $ 6,658,987 $ 6,649,762 Change orders 1,212,153 846,464 Maintenance 4,803,171 5,107,764 Software licenses 7,885,023 3,975,549 Professional services 3,843,641 3,145,883 Hosting 1,016,535 985,415 Total $ 25,419,510 $ 20,710,837 COST OF GOODS SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company ’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs . CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 The carrying amount reported in the accompanying consolidated balance sheets approximates fair value. ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $179,813 December 31, 2016 $116,834 December 31, 2015. The following table summarizes activity in the Company's allowance for doubtful accounts for the years presented. December 31, 2016 December 31, 2015 Beginning of period $ 116,834 $ 186,085 Bad debt expense 132,767 14,939 Write-offs (69,788 ) (84,190 ) End of period $ 179,813 $ 116,834 CONCENTRATION OF CREDIT RISK Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may December 31, 2016, $1,237,118 Except as follows, the Company has no significant off balance sheet risk or credit risk concentrations. Financial instruments that subject the Company to potential credit risks are principally cash equivalents and accounts receivable. Concentrated credit risk with respect to accounts receivable is limited to creditworthy customers. The Company's customers are principally located in the United States, Europe and East Asia. The Company is directly affected by the overall financial condition of the pharmaceutical, biotechnology and medical device industries and management believes that credit risk exists and that any credit risk the Company faces has been adequately reserved for as of December 31, 2016. December 31, 2016, One customer accounted for 16% December 31, 2016 $4,167,000, 16% December 31, 2015 $3,237,000. 10% Two customers each individually accounted for approximately 11% December 31, 2016. 16% December 31, 2015. Revenues Accounts receivable For the year ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2016 1 16% 2 21% December 31, 2015 1 16% 3 42% The table below provides revenues from European customers for the years ended December 31, 2016 December 31, 2015, European revenues For the year ended December 31, 2016 December 31, 2015 European revenues % of Total revenues European revenues % of Total revenues $ 2,702,660 11% $ 2,150,096 10% The Company serves all of its hosting customers from third third may PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3 ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805”) 350, Intangibles- Goodwill and Other 350”). The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no more for an asset than its replacement or reproduction cost. The market approach estimates value based on what other participants in the market have paid for reasonably similar assets. Although each valuation approach is considered in valuing the assets acquired, the approach ultimately selected is based on the characteristics of the asset and the availability of information. Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may ’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value. DEFERRED REVENUE Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may December 31, 2016, $9,539,230 1 5 $7,250,061 twelve ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $712,179 December 31, 2016 $635,267 December 31, 2015 RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are included in research and product development and are expensed as incurred. ASC 985.20, 985.20. December 31, 2016 $2,598,962 December 31, 2015 $2,639,577, activities, which include costs associated with the development of our software products and services for our client’s projects and which are primarily comprised of salaries and related expenses for our software developers and consulting fees paid to third costs are primarily included under Salaries, benefits and related taxes in our Statement of Operations. EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. The 2016 10,000,000 2016 January 1st nine (9) January 1, 2017 January 1, 2025, five (5%) 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 The 2009 7.5 2009 Each plan is more fully described in “Note 13, ASC 718, ASC 718 ’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value. EARNINGS/(LOSS) PER SHARE The Company accounts for Earnings/(loss) Per Share using ASC 260 – Earnings per Share. Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities. INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, 740 Valuation allowances are established, when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. IMPACT OF NEW ACCOUNTING STANDARDS During fiscal 2016, In February 2016, ASU”) No. 2016 02, “Leases (Topic 842)” 2016 02”). 12 December 15, 2019. In March 2016, ASU No. 2016 09, “Compensation – Stock Compensation (Topic 718)”, 2016 09”). December 15, 2016, In March 2016, April 2016, December 2016, 2016 08, Revenue from Contracts with Customers - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) 2016 08”), 2016 10, Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing 2016 10”), 2016 20, Technical Corrections and Improvements to Topic 606, 2016 20”) 2014 09. May 2016, 2016 12, Revenue from Contracts with Customers - Narrow Scope Improvements and Practical Expedients 2014 09, December 15, 2016, Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements. |
Note 3 - Earnings (Loss) Per Sh
Note 3 - Earnings (Loss) Per Share | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Earnings Per Share [Text Block] | NOTE 3: EARNINGS/(LOSS) PER SHARE Basic income/(loss) per share was calculated using the weighted average number of shares outstanding of 145,868,227 December 31, 2016 96,645,482 December 31, 2015. Anti-dilutive shares aggregating 43,775,016 for the year ended December 31, 2016 27,356,310 December 31, 2015 December 31, 2016 December 31, 2015 December 31, 2016 December 31, 2015. Anti-dilutive security December 31, 2016 December 31, 2015 Preferred stock -0- 3,277,229 Employee stock options 275,000 125,000 Warrants 27,860,000 22,900,000 Convertible notes 15,490,000 -0- Shares issuable for accrued interest 150,016 1,054,081 Total 43,775,016 27,356,310 The employee stock options are exercisable at prices ranging from $0.045 $0.24 per share. The exercise price on the stock warrants range from $0.25 $0.60 $0.25 $0.50 The Company ’s convertible debt and convertible preferred stock have an anti-dilutive effect on net income/(loss) per share and were not included in the computation of diluted income/(loss) per share. For the year ended December 31, 2016 December 31, 2015 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 101,880 145,868,227 $ 0.00 $ 2,404,498 96,645,482 $ 0.02 Effect of dilutive securities -0- 294,200 0.00 43,316 16,900,259 0.00 Diluted EPS $ 101,880 146,162,427 $ 0.00 $ 2,447,814 113,545,741 $ 0.02 |
Note 4 - Property and Equipment
Note 4 - Property and Equipment, Net | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | NOTE 4 : PROPERTY AND EQUIPMENT, NET Property and equipment consists of the following: December 31, 2016 December 31, 2015 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 2,125,067 $ 1,761,879 $ 363,188 $ 2,055,956 $ 1,605,473 $ 450,483 5 Leasehold improvements 114,719 89,789 24,930 91,452 85,895 5,557 5 Computer software 1,925,462 1,720,399 205,063 1,843,483 1,621,492 221,991 3 Office furniture 158,436 114,065 44,371 111,660 105,979 5,681 5 Total $ 4,323,684 $ 3,686,132 $ 637,552 $ 4,102,551 $ 3,418,839 $ 683,712 Depreciation expense was $302,893 December 31, 2016 $233,798 December 31, 2015. |
Note 5 - Intangible Assets, Net
Note 5 - Intangible Assets, Net | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Intangible Assets Disclosure [Text Block] | NOTE 5 : INTANGIBLE ASSETS, NET Intangible assets consist of the following: December 31, 2016 December 31, 2015 Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer list $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer list 104,163 21,990 82,173 108,051 15,607 92,444 15 Promasys B.V. software code 72,837 46,130 26,707 72,837 31,563 41,274 5 Promasys B.V. URLs/website 52,608 52,608 -0- 54,572 39,413 15,159 3 Total $ 1,622,309 $ 1,513,429 $ 108,880 $ 1,628,161 $ 1,479,284 $ 148,877 Amortization expense was $ 37,331 December 31, 2016 $40,338 December 31, 2015. Annual amortization expense for the Company ’s intangible assets is as follows: 2017 $ 21,512 2018 19,084 2019 6,944 2020 6,944 2021 6,944 Thereafter 47,452 Total $ 108,880 |
Note 6 - Accounts Payable and A
Note 6 - Accounts Payable and Accrued Expenses | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | NOTE 6 : ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following: Account December 31, 2016 December 31, 2015 Accounts payable $ 697,060 $ 515,764 Accrued payroll and related costs 886,334 473,108 Other accrued expenses 431,961 105,562 Accrued interest 107,718 862,836 Total accounts payable and accrued expenses $ 2,123,073 $ 1,957,270 |
Note 7 - Line of Credit, Notes
Note 7 - Line of Credit, Notes Payable and Liquidity | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | NOTE 7: LINE OF CREDIT, NOTES PAYABLE AND LIQUIDITY On March 18, 2013, $2,000,000 2.0% $9,500 December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. February 2, 2018 December 31, 2016, $2,700,000 2.75%. Our primary sources of working capital are funds from operations and borrowings under our revolving Line of Credit. In the event that the line of credit is called for any reason, Mr. Wit has pledged to replace the borrowing capacity under the Line of Credit with a promissory note that utilizes the same maturity date and interest rate as the Line of Credit. To satisfy our capital requirements, we may may may At December 31, 2016, $1,242,500 Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2016 Current term Current term 2/29/2016 4/1/2019 12% $ 450,000 $ -0- $ -0- $ -0- $ 450,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 372,500 -0- 372,500 -0- -0- Discount on notes payable -0- (455,285 ) -0- (237,664 ) Total $ 1,242,500 $ -0- $ 337,215 $ -0- $ 212,336 At December 31, 2015, $812,500 Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2015 Current term Current term 4/4/2014 4/1/2017 12% $ 45,000 $ -0- $ 45,000 $ -0- $ -0- 4/4/2014 4/1/2017 12% 137,500 -0- 137,500 -0- -0- 4/4/2014 4/1/2017 10% 120,000 -0- 120,000 -0- -0- 12/1/2014 4/1/2017 10% 300,000 -0- 300,000 -0- -0- 12/1/2014 4/1/2017 12% 90,000 -0- 90,000 -0- -0- 12/1/2014 4/1/2017 12% 100,000 -0- 100,000 -0- -0- 4/1/2015 4/1/2018 12% 20,000 -0- -0- -0- 20,000 Discount on notes payable -0- -0- -0- -0- Total $ 812,500 $ -0- $ 792,500 $ -0- $ 20,000 On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. On December 5, 2016 1,000,000 This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $325,689 $124,311. 37 On June 30, 2016, $372,500 1,490,000 $0.25 April 1, 2020 two 12% April 1, 2020. On December 14, 2016 $90,000 This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $246,921 $125,579. 45 On June 30, 2016, $420,000 1,680,000 $0.25 April 1, 2020 two 10% April 1, 2020. This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $278,408 $141,592. 45 On January 31, 2015 $529,000 Mr. Wit in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% April 1, 2017. April 1, 2017. October 15, 2015 $529,000 12% January 1, 2019. January 1, 2019. November 19, 2015 2,116,000 On January 31, 2015 $2,860,000 $6,879 12% April 1, 2017. April 1, 2017. October 15, 2015 $2,860,000 12% January 1, 2019. January 1, 2019. November 19, 2015 11,440,000 11,440,000 On January 31, 2015, $950,000 3,800,000 Company at an exercise price of $0.25 April 1, 2017 $280,000 $670,000. 12% April 1, 2017. October 15, 2015 $950,000 12% January 1, 2019. January 1, 2019. November 19, 2015 3,800,000 On April 1, 2015 $20,000 12% April 1, 2018. December 14, 2016. On October 15 , 2015 $980,000 12% January 1, 2019. January 1, 2019. November 19, 2015 3,920,000 On October 15 , 2015 $1,600,000 12% January 1, 2019. January 1, 2019. November 19, 2015 400,000 6,000,000 6,400,000 November 23, 2015 4,000,000 three December 17, 2015 2,000,000 fourth |
Note 8 - Convertible Notes Paya
Note 8 - Convertible Notes Payable | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Convertible Debt Disclosure [Text Block] | NOTE 8: CONVERTIBLE NOTES PAYABLE The following table summarizes the convertible debt outstanding as of December 31, 2016. Principal at Carrying amount Date of Maturity Interest December 31, Short term Long term issuance date rate 2016 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2018 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2018 12% 200,000 -0- -0- -0- 200,000 12/16/2008 4/1/2020 12% 100,000 -0- -0- -0- 100,000 12/16/2008 4/1/2020 12% 4,055,000 -0- -0- 4,055,000 -0- 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 9/30/2009 4/1/2020 12% 625,000 -0- -0- -0- 625,000 Total $ 7,050,000 $ -0- $ 50,000 $ 5,825,000 $ 1,175,000 The following table summarizes the convertible debt outstanding as of December 31, 2015. Principal at Carrying amount Date of Maturity Interest December 31, Short term Long term issuance date rate 2015 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 75,000 $ -0- $ 75,000 $ -0- $ -0- 8/29/2008 4/1/2017 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2017 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2017 12% 260,000 -0- -0- -0- 260,000 12/16/2008 4/1/2017 12% 4,055,000 -0- -0- 4,055,000 -0- 12/16/2008 4/1/2018 12% 215,000 -0- -0- -0- 215,000 12/16/2008 4/1/2018 12% 25,000 -0- -0- 25,000 -0- 9/30/2009 4/1/2017 12% 625,000 -0- -0- -0- 625,000 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 Total $ 7,275,000 $ -0- $ 75,000 $ 5,850,000 $ 1,350,000 10% During 1999 10% $862,500 There were costs of $119,625 $742,875. 10% June 30, 2004, $1.25 December 31, 2016, $812,500 1,495,179 $50,000. $88,210 December 31, 2016. Secured Convertible Debentures On September 30, 2009 $1,400,000 12% 5,600,000 $0.25 four four Chief Executive Officer and Director, Cornelis F. Wit (“Mr. Wit”). The Company received net proceeds of $1,400,000. 12% March 30, 2011. $0.25 On March 30, 2011 $200,000 $1,200,000 April 1, 2013, $1,100,000 Mr. Wit. The Company also extended the expiration date of the warrants associated with the September 2009 On February 22, 2013 and two $1,200,000 January 1, 2016, $1,100,000 September 2009 January 1, 2016. On January 31, 2015 $1,100,000 September 2009. 12% April 1, 2017. April 1, 2017. November 19, 2015 $475,000 1,900,000 November 19, 2015 1,900,000 $475,000 $475,000 1,900,000 November 23, 2015 $625,000 two On April 1, 2015 $100,000 to April 1, 2018. April 1, 2018. On June 30, 2016 two $625,000 April 1, 2020. April 1, 2020. Convertible Debentures August 2008 On August 29, 2008 $2,270,000 4,540,000 four Chief Executive Officer and Director, Cornelis F. Wit and one 10% August 29, 2010. $0.50 On September 30, 2009 two $1,920,000 August 29, 2013 On February 22, 2013 $1,770,000 f the convertible debentures to January 1, 2016. January 1, 2016. On February 22, 2013 $150,000 former Director, Guus van Kesteren (“Mr. van Kesteren”) to January 1, 2015. January 1, 2015. On April 21, 2014 the Company and Mr. van Kesteren, extended the maturity date of his $150,000 April 1, 2016. April 1, 2016. July 31, 2014 $150,000 On January 31, 2015 $1,770,000 April 1, 2017. April 1, 2017. On June 30, 2015 $150,000 o April 1, 2017. April 1, 2017. On June 30, 2016 $1,770,000 April 1, 2020. April 1, 2020. On June 30, 2016 $150,000 April 1, 2018. April 1, 2018. December 2008 On December 16, 2008 $5,075,000 10,150,000 eleven Chief Executive Officer and Director, Cornelis F. Wit (“Mr. Wit”), our Chief Operating Officer and President, Stephen E. Johnson (“Mr. Johnson”), our Chairman and Chief Technology Officer, Randall G. Smith (“Mr. Smith”), Chief Financial Officer, Ronald T. Linares, and four 12% December 16, 2010. $0.50 On September 30, 2009 seven $4,980,000 December 16, 2013 On February 22, 2013 $4,505,000 $4,475,000 Mr. Wit, $25,000 $5,000 January 1, 2016. January 1, 2016. On February 27, 2013 $15,000 , Matthew Veatch, to January 1, 2016. January 1, 2016. On March 6, 2013 der agreed to extend the maturity date of $200,000 January 1, 2014. January 1, 2014. On March 12, 2013 the holder agreed to extend the maturity date of $100,000 January 1, 2015. January 1, 2015. In December 2013 two agreed to extend the maturity date of $360,000, $160,000 January 1, 2016. January 1, 2016. July 31, 2014 $160,000 On April 28, 2014 the Company and the holder extended the maturity date of $100,000 December 2008. 12% April 1, 2016. April 1, 2016. On January 31, 2015 $4,475,000 December 2008. 12% April 1, 2017. April 1, 2017. November 19, 2015 $420,000 1,680,000 1,680,000 On April 27, 2015 $200,000 December 2008. 12% April 1, 2018. April 1, 2018. On April 30, 2015 $25,000 December 2008. 12% April 1, 2018. April 1, 2018. December 14, 2016. On May 1, 2015 $5,000 $5,000 December 2008. On May 1, 2015 Mr. van Kesteren extended the maturity date of $160,000 December 2008. 12% April 1, 2017. April 1, 2017. On May 7, 2015 the Company and our former Director, Matthew Veatch, extended the maturity date of $15,000 April 1, 2018. April 1, 2018. December 14, 2016. On June 30, 2015 the Company and the holder extended the maturity date of $100,000 December 2008. 12% April 1, 2017. April 1, 2017. On June 30, 2016 $4,055,000 April 1, 2020. April 1, 2020. On June 30, 2016 $160,000 April 1, 2018. April 1, 2018. The convertible debentures were repaid in full on December 14, 2016. On June 30, 2016 $100,000 April 1, 2020. April 1, 2020. December 2009 On December 31, 2009 $1,490,000 5,960,000 $0.25 four three Chief Executive Officer and Director, Cornelis F. Wit (“Mr. Wit”). The convertible debentures, which bear interest at 12% June 30, 2011. $0.25 On September 30, 2011 $1,490,000 October 1, 2013, $1,440,000 Mr. Wit. The Company also extended the expiration date of the warrants associated with the debentures to December 31, 2016. On February 22, 2013 $1,490,000 January 1, 2016, $1,440,000 Mr. Wit. The Company also extended the expiration date of the warrants associated with the debentures offering until January 1, 2016. On January 31, 2015 $1,440,000 April 1, 2017. April 1, 2017. November 19, 2015 $1,440,000 5,760,000 November 19, 2015 5,760,000 $1,440,000 5,760,000 On April 1, 2015 $50,000 December 2009. 12% April 1, 2018. December 7, 2015. The payments required at maturity under the Company’s outstanding convertible debt at December 31, 2016 2017 $ 50,000 2018 450,000 2019 -0- 2020 6,550,000 Total $ 7,050,000 |
Note 9 - Fair Value Measurement
Note 9 - Fair Value Measurement | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Fair Value Disclosures [Text Block] | NOTE 9 : FAIR VALUE MEASUREMENT The Company measures the fair value of its assets and liabilities under the guidance of ASC 820, 820 ASC 820 820 ● Level 1: ● Level 2: rvable either directly or indirectly such as quoted prices for similar assets or liabilities or market-corroborated inputs; and ● Level 3: assumptions about how market participants would price the assets or liabilities. The valuation techniques that may ● Market approach - Uses prices and other relevant information generated by market transactio ns involving identical or comparable assets or liabilities ● Income approach - Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques , option-pricing models and excess earnings method ● Cost approach - Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost) The Company also adopted the provisions of ASC 825, ASC 825 may December 31, 2016 December 31, 2015. The Company ’s financial assets or liabilities subject to ASC 820 December 31, 2016 2008 2009, 2011 2016 2013. 815 Disclosures about Derivative Instruments and Hedging Activities 8 Following is a description of the valuation methodologies used to determine the fair value of the Company ’s financial assets including the general classification of such instruments pursuant to the valuation hierarchy. A summary as of December 31, 2016 Fair value at Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2016 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Derivatives: (1) (2) Conversion feature liability $ 2,325,730 $ -0- $ -0- $ 2,325,730 Warrant liability 3,999,362 -0- -0- 3,999,362 Total of derivative liabilities $ 6,325,092 $ -0- $ -0- $ 6,325,092 (1) The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2016 (2) The fair value at the measurement date is equal to the carrying value on the balance sheet Significant valuation assumptions for derivative instruments at December 31, 2016 Risk free interest rate 0.82% to 1.45% Dividend yield 0.00% Expected volatility 117.3% to 143.8% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25 A summary as of December 31, 2016 Carrying amount Carrying amount Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2015 December 31, 2016 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 92,444 $ 82,173 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 41,274 26,707 -0- -0- 72,943 Promasys B.V. URLs/website (4) 15,159 -0- -0- -0- 68,814 Total $ 148,877 $ 108,880 $ -0- $ -0- $ 278,010 (3) The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied. (4) The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction. A summary as of December 31, 2015 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2015 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 901,243 $ -0- $ -0- $ 901,243 Warrant liability 1,914,923 -0- -0- 1,914,923 Total of derivative liabilities $ 2,816,166 $ -0- $ -0- $ 2,816,166 (1) The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2015 (2) The fair value at the measurement date is equal to the carrying value on the balance sheet Significant valuation assumptions for derivative instruments at December 31, 2015 Risk free interest rate 0.48% to 1.2% Dividend yield 0.00% Expected volatility 91.0% to 132.2% Expected life (range in years) Conversion feature liability 1.25 to 2.25 Warrant liability 0.00 to 3.01 A summary as of December 31, 2015 Carrying Amount Carrying Amount Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2014 December 31, 2015 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 110,948 $ 92,444 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 55,842 41,274 -0- -0- 72,943 Promasys B.V. URLs/website (4) 37,131 15,159 -0- -0- 68,814 Total $ 203,921 $ 148,877 $ -0- $ -0- $ 278,010 (3) The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied. (4) The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction. Other identifiable intangible assets, which are subject to amortization, are being amortized using the straight-line method over their estimated useful lives ranging from 3 15 may Other income/(expense) For the year ended December 31, 2016 December 31, 2015 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date $ (2,657,910 ) $ 4,525,798 Total unrealized and realized gains/(losses) included in earnings $ (2,657,910 ) $ 4,525,798 The tables below set forth a summary of changes in fair value of the Company ’s Level 3 December 31, 2016 December 31, 2015. 3 December 31, 2016 December 31, 2015. Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2016 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (901,243 ) $ 29,108 $ (1,453,595 ) $ -0- $ -0- $ (2,325,730 ) Warrant liability (1,914,923 ) -0- (1,233,423 ) (851,016 ) -0- (3,999,362 ) Total of derivative liabilities $ (2,816,166 ) $ 29,108 $ (2,687,018 ) $ (851,016 ) $ -0- $ (6,325,092 ) Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2015 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (2,944,402 ) $ 29,875 $ 2,013,284 $ -0- $ -0- $ (901,243 ) Warrant liability (6,695,060 ) -0- 2,482,639 (868,128 ) 3,165,626 (1,914,923 ) Total of derivative liabilities $ (9,639,462 ) $ 29,875 $ 4,495,923 $ (868,128 ) $ 3,165,626 $ (2,816,166 ) |
Note 10 - Commitments and Conti
Note 10 - Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Commitments and Contingencies Disclosure [Text Block] | NOTE 1 0 : COMMITMENTS AND CONTINGENCIES The Company currently leases office space under operating leases for its office locations and has several operating leases related to server and network co-location and disaster recovery for its operations. The minimum future lease payments required under the Company’s operating leases at December 31, 2016 2017 $ 655,832 2018 512,157 2019 421,230 2020 297,570 2021 269,962 Thereafter 310,550 Total $ 2,467,301 In addition to annual base rental payments, the Company pays for the operating expenses associated with its leased office space and is responsible for any escalation in operating expenses as determined in the leases. Rent expense was $1,071,363 December 31, 2016 $972,862 December 31, 2015. The Company ’s corporate office lease expires in February 2023. March 2021. September 2017. July 2017. October 2018. LEGAL PROCEEDINGS From time to time the Company may December 31, 2016, PATENT LITIGATION SETTLEMENT Effective April 2, 2009, June 18, 2008 6,496,827 B2 , and (ii) released us from any and all claims of infringement of the Licensed Patent which may may January 1, 2008 May 12, 2018 two (2%) 2017 $450,000 may 1,000,000 $.01 second April 2, 2011, May 12, 2018. $300,000 The remaining minimum royalty payments per year are as follows: 2017 $ 450,000 2018 164,500 Total $ 614,500 On June 23, 2009, Concurrent with the consummation of that transaction we entered into the First Amendment to Settlement and Licensing Agreement with DataSci, (i) to include the eResearch Technology EDC assets acquired within the definition of Licensed Products, and as such subject to the royalty payment(s), under and in accordance with the Settlement and Licensing Agreement, and (ii) provide a release by DataSci of any and all claims of infringement of the Licensed Patent in connection with the eResearch Technology EDC assets acquired which may $300,000. The Company recorded a charge to earnings of $94,129 December 31, 2016 $244,747 December 31, 2015, (1) December 31, 2016 December 31, 2015 (2) EMPLOYMENT AGREEMENTS The Company has employment agreements in place with the following members of our executive management team: Cornelis F. Wit, Chief Executive Officer Randall G. Smith, Chief Technology Officer Stephen E. Johnson, President and Chief Operating Officer The employment agreements provide, among other things, for participation in employee benefits available to employees and executives. Each of the agreements will renew for successive one ninety may ’s employment upon 30 may |
Note 11 - Related Party Transac
Note 11 - Related Party Transactions | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | NOTE 1 1 : RELATED PARTY TRANSACTIONS On April 1, 2015 $20,000 (“Mr. Smith”), in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% April 1, 2018. December 14, 2016. On April 30, 2015, $25,000 December 2008. 12% April 1, 2018. April 1, 2018. The convertible debentures were repaid in full on December 14, 2016. On May 1, 2015 $5,000 Mr. Smith in exchange for an outstanding convertible note in the same amount. The note carried an interest rate of 12% January 1, 2016. As of December 31, 2016, $5,825,000 $450,000 ● In June 2008, $510,000 August 29, 2008, $510,000 $1,260,000 3,540,000 10% August 29, 2010. $0.50 September 30, 2009, $1,770,000 August 29, 2013 February 22, 2013, $1,770,000 January 1, 2016. January 1, 2016. January 31, 2015 $1,770,000 April 1, 2017. April 1, 2017. June 30, 2016 $1,770,000 April 1, 2020. April 1, 2020. ● In February 2008, $150,000 September 2008 December 2008, $4,200,000 December 16, 2008, $4,350,000 8,700,000 12% December 16, 2010. $0.50 September 30, 2009, $4,350,000 December 16, 2013 October 16, 2012, $125,000 December 2008 250,000 February 22, 2013, $4,475,000 January 1, 2016. January 1, 2016. January 31, 2015 $4,475,000 April 1, 2017. April 1, 2017. November 19, 2015 $420,000 1,680,000 1,680,000 . On June 30, 2016 $4,055,000 April 1, 2020. April 1, 2020. ● From July 2009 September 2009, $1,100,000 one September 30, 2009. September 30, 2009, 12% March 30, 2011. 4,400,000 4,400,000 $0.25. March 30, 2011, April 1, 2013 4,400,000 two September 30, 2015. February 22, 2013, January 1, 2016 January 1, 2016. January 31, 2015 $1,100,000 April 1, 2017. April 1, 2017. November 19, 2015 $475,000 1,900,000 November 19, 2015 1,900,000 $475,000 $475,000 1,900,000 November 23, 2015 $625,000 two . ● From October 2009 December 2009, $1,440,000, one December 31, 2009. December 31, 2009, 12% June 30, 2011. October 1, 2013 5,760,000 two December 31, 2015. February 22, 2013, January 1, 2016 January 1, 2016. January 31, 2015 $1,440,000 April 1, 2017. April 1, 2017. November 19, 2015 $1,440,000 5,760,000 November 19, 2015 5,760,000 $1,440,000 5,760,000 ● On January 1, 2014, $980,000 3,920,000 $0.25 April 1, 2017 $980,000. 12% April 1, 2017. October 15, 2015 $980,000 12% January 1, 2019. January 1, 2019. November 19, 2015 3,920,000 ● On January 31, 2015 $2,860,000 $6,879 12% April 1, 2017. April 1, 2017. October 15, 2015 $2,860,000 12% January 1, 2019. January 1, 2019. November 19, 2015 11,440,000 11,440,000 . ● On January 31, 2015 $529,000 12% April 1, 2017. April 1, 2017. October 15, 2015 $529,000 12% January 1, 2019. January 1, 2019. November 19, 2015 2,116,000 ● On January 31, 2015, $950,000 3,800,000 $0.25 April 1, 2017 $280,000 $670,000. 12% April 1, 2017. October 15, 2015 $950,000 12% January 1, 2019. January 1, 2019. November 19, 2015 3,800,000 . ● On November 19, 2015 37,023,517 $6,919,000 12% $420,000 12% 29,363,517 $0.25 $1,915,000 $0.25 ● On February 29, 2016, $450,000 1,800,000 $0.25 April 1, 2019 $450,000. 12% April 1, 2019. On March 18, 2013, $2,000,000 guaranteed by Mr. Wit. On December 18, 2013 $4,000,000. February 3, 2015 $5,000,000. 2.0% $9,500 February 2, 2018 December 31, 2016, $2,700,000 2.75%. The Company incurred interest expense payable to related parties of $918,189 year ended December 31, 2016 $2,434,101 year ended December 31, 2015. |
Note 12 - Stockholders' (Defici
Note 12 - Stockholders' (Deficit) | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 1 2 : STOCKHOLDERS’ (DEFICIT) Our authorized capital stock consists of 500,000,000 $.001 10,000,000 $.001 5,000,000 5% 230,000 747,500 250,000 As of December 31, 2016 ● 1 47,786,917 ● 2 7 ,86 0,000 ● - 0 shares of our Series A Preferred Stock issued and outstanding; ● - 0 Preferred Stock issued and outstanding; ● - 0 Preferred Stock issued and outstanding; ● 250,000 ● $ 7 ,05 0,000 15,490,000 Common Stock Holders of common stock are entitled to one Holders of our voting securities do not have cumulative voting rights. Holders of common stock are entitled to share in all dividends that the Board of Directors, in its discretion, declares from legally available funds. In the event of our liquidation, dissolution or winding up each outstanding share of common stock entitles its holder to participate in all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over the common stock. Holders of common stock have no conversion, preemptive or other subscription rights, and there are no redemption provisions for the common stock. The rights of the holders of common stock are subject to any rights that may On March 20, 2015 665,000 2009 3 On March 23, 2015 7,500 On April 29, 2015 5,800 On June 11, 2015 360,000 2009 3 On June 15, 2015 225,000 On June 30, 2015 20,000 On July 17, 2015 66,668 ’s service. On August 21, 2015 1,628 On October 16, 2015 50,002 On November 19, 2015 37,023,517 Cornelis F. Wit, our Chief Executive Officer and Director. The shares were issued in exchange (i) for the cancellation of $6,919,000 12% $420,000 12% 29,363,517 $0.25 $1,915,000 $0.25 On December 31, 2015 four 5% 487,500 1,950,000 During the first four 2016 14,615,696 On A pril 13, 2016 3,012 On A pril 25, 2016 1,000,000 On A pril 26, 2016 1,594 On June 1 6, 2016 360,000 2009 3 On July 20, 2016 3,038 On December 30, 2016 2011. 100,000 The 2009 1 3, Preferred stock Our Board of Directors, without further stockholder approval, may one may ● dividend and liquidation preferences, ● voting rights, ● conversion privileges, and ● redemption terms. Our Board of Directors may In addition, our Board of Directors can fix limitations and restrictions, if any, upon the payment of dividends on our common stock to be effective while any shares of preferred stock are outstanding. The following table presents the cumulative arrearage of undeclared dividends by class of preferred stock as of December 31, 2016 December 31, 2015 Cumulative arrearage as of Cumulative arrearage per share as of December 31, December 31, Series of preferred stock 2016 2015 2016 2015 Series A $ -0- $ 2,465,830 $ -0- $ 0.68 Series B 609,887 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 4,547,810 Series A Preferred Stock In 1999, 5,000,000 5% - 0 The designations, rights and preferences of the Series A Preferred include: ● the shares are not redeemable, ● each share of Series A Preferred Stock is convertible into shares of our common stock at any time at the option of the holder at a conversion price of $1. 11 one $3.00 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share. The Series A Preferred Stockholders have waived their rights to an anti-dilution adjustment reducing their conversion price as a result of the issuance of the Series B Preferred Stock and Series C Preferred Stock, ● the shares of Series A Preferred Stock pay a cumulative dividend at a rate of 5% $1.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series A Preferred Stock, ● in the event of our liquidation or winding up, each share of Series A Preferred Stock has a liquidation preference equal to $1.00 and ● the holders of the Series A Preferred Stock are entitled to vote together with the holders of our common stock, on the basis of one In addition, the holders of the Series A Preferred Stock were granted certain demand and piggy-back registration rights for the shares of our common stock issuable upon the conversion of the Series A Preferred Stock. There were cumulative arrearages of $ - 0 $2,465,830, $0.00 $0.68 December 31, 2016 December 31, 2015 Prior to 2015 235,000 5% In December 2015 34 Series A Preferred Shareholders. The terms of the exchange offer were 4 December 31, 2015 four 5% 487,500 1,950,000 first 4 2016, 3,637,724 14,615,696 Series B Preferred Stock In August 2001, 200,000 February 7, 2002 230,000 0 The designations, rights and preferences of the Series B Preferred Stock include: ● the stated value of each share is $10.00 ● the shares are not redeemable, ● each share of Series B Preferred Stock is convertible into shares of our common stock at the option of the holder at any time commencing January 31, 2002 $0.25 $0.25 $25 $0.75 We may $0.50 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share or market value of the common stock, ● the shares of Series B Preferred Stock pay a cumulative dividend at a rate of 8% $10.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series B Preferred Stock, ● each share of Series B Preferred Stock will rank senior to our Series A Preferred and pari passu with our Series C Preferred Stock, ● in the event of our liquidation or winding up, each share of Series B Preferred Stock has a liquidation preference equal to $10.00 ● the holders of the Series B Preferred Stock are entitled to vote, together with the holders of our common stock, on the basis of one There were cumulative arrearages of $609,887 $609,887, $3.05 $3.05 December 31, 2016 December 31, 2015, The Company has 200,000 Pursuant to Delaware General Corporate Law, once the Company has a positive net worth, the cumulative dividends would be payable in either cash or in shares of our common stock upon the declaration of dividends by our board of directors. In addition, the holders of the Series B Preferred Stock were granted certain mandatory and piggy-back registration rights for the shares of our common stock issuable upon the conversion of the Series B Preferred Stock and are entitled to vote one Series C Preferred Stock In March 2002, 747,500 0 The designations, rights and preferences of the Series C Preferred Stock include: ● the stated value of each share is $10.00 ● the shares are not redeemable, ● each share of Series C Preferred Stock is convertible at any time, at the option of the holder, into a number of shares of common stock determined by dividing the stated value per share of the Series C Preferred Stock by $0.25, The Series C Preferred Stock will automatically convert, subject to limitations based on trading volume, into shares of our common stock upon a public offering of our securities raising gross proceeds in excess of $25,000,000 2.5 two 20 30 10 20 ● the conversion price has certain anti-dilution protections for any stock splits, stock dividends, and corporate reorganizations, and certain other corporate transactions and issuances of securities at below the applicable conversion price per share or market value of the common stock, ● the shares of Series C Preferred Stock pay a cumulative dividend at a rate of 8% $10.00 At our option, dividends can be paid in cash or shares of common stock valued at the conversion price of the Series C Preferred Stock, ● each share of Series C Preferred Stock will rank pari passu with our Series B Preferred Stock and senior to our Series A Preferred Stock, ● in the event of our liquidation or winding up, each share of Series C Preferred Stock has a liquidation preference equal to $10.00 ● the holders of the Series C Preferred Stock are entitled to vote, together with the holders of our common stock, on the basis of one There were cumulative arrearages of $1,472,093 $1,472,093, $4.3 7 $4.37 December 31, 2016 December 31, 2015, The Company has 337,150 Pursuant to Delaware General Corporate Law, once the Company has a positive net worth, the cumulative dividends would be payable in either cash or in shares of our common stock upon the declaration of dividends by our board of directors. In addition, the holders of the Series C Preferred Stock were granted certain mandatory and piggy-back registration rights covering the shares of our common stock issuable upon the conversion of the Series C Preferred Stock and are entitled to vote two Series D Preferred Stock In November 2010, 250,000 250,000 The designations, rights and preferences of the Series D Preferred Stock include: ● the stated value of the Series D Preferred is $0.001 ● the Series D Preferred has no rights to receive dividend distributions or to participate in any dividends declared by the Corporation to or for the benefit of the holders of its common stock, ● the shares of Series D Preferred are not convertible into or exchangeable for any ot her security of the Corporation, ● except as provided in Series D Preferred Designation, in the case of the death or disability of Series D Preferred holder, the Series D Preferred is not redeemable without the prior express written consent of the holders of the majority of the voting power of all then outstanding shares of such Series D Preferred. In the event any shares of Series D Preferred are redeemed pursuant, the shares redeemed will automatically be canceled and returned to the status of authorized but uni ssued shares of preferred stock, ● each share of Series D Preferred entitles the holder to four (400) ● in the event of the liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, the holders of shares of the Series D Preferred then outstanding are entitled to receive before holders of shares of common stock receive any amounts, out of the remaining assets of the Corporation available for distribution to its stockholders, an amount equal to $0.001 r share, ● so long as any shares of Series D Preferred are outstanding, the Company cannot without first res of Series D Preferred Stock, ● the holders of the Series D Preferred are not entitled to rights to subscribe for, purchase or receive any part of any new or additional shares of any class, whether now or hereinafter authorized, or of bonds or debentures, or other evidences of indebtedness convertible into or exchangeable for shares of any class, ● the Company has a thirty (30) first The Company must purchase all of those shares of Series D Preferred offered by the holder of the Series D Preferred Stock, and ● the holders of Series D Preferred cannot, directly or indirectly, transfer any shares of Series D Preferred. Any such purported transfer shall be of no force or effect and shall not be recognized by the Company. The following table presents preferred dividends accreted for the years ended December 31, 2016 December 31, 2015, Dividends accreted Dividends per share For the year ended For the year ended December 31, December 31, 2016 2015 2016 2015 Preferred stock dividends in arrears Series A $ -0- $ 181,886 $ -0- $ 0.050 Preferred stock dividends in arrears Series B $ -0- $ -0- $ -0- $ -0- Preferred stock dividends in arrears Series C $ -0- $ -0- $ -0- $ -0- Warrants Issued for Services and in Capital Transactions The following tables summarize all warrants issued as part of debt transactions for the year ended December 31, 2016 December 31, 2015, December 31, 2016 December 31, 2016 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 - $0.60 27,860,000 2.71 $ 0.42 27,860,000 $ 0.42 December 31, 2015 December 31, 2015 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 - $0.60 22,900,000 1.76 $ 0.46 22,900,000 $ 0.46 Warrants Balance at December 31, 2014 48,463,517 Issued 3,800,000 Exercised -0- Cancelled (29,363,517 ) Expired/forfeited -0- Balance at December 31, 2015 22,900,000 Issued 4,970,000 Exercised -0- Expired/forfeited (10,000 ) Balance at December 31, 2016 27,860,000 Warrants exercisable at December 31, 2016 27,860,000 Weighted average fair value of warrants granted during 2016 $ 0.16 Other Comprehensive (Loss) Due to the availability of net operating losses and related deferred tax valuations, there is no tax effect associated with any component of other comprehensive (loss). The following table lists the beginning balance, yearly activity and ending balance of the components of accumulated other comprehensive (loss). Foreign currency translation Accumulated other comprehensive (loss) Balance at December 31, 2014 $ (243,827 ) $ (243,827 ) 2015 Activity (122,528 ) (122,528 ) Balance at December 31, 2015 (366,355 ) (366,355 ) 2016 Activity (44,150 ) (44,150 ) Balance at December 31, 2016 $ (410,505 ) $ (410,505 ) |
Note 13 - Employee Equity Incen
Note 13 - Employee Equity Incentive Plans | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | NOTE 1 3 : EMPLOYEE EQUITY INCENTIVE PLANS Stock Option Plans Description of 2016 In 2016, ’s Board of Directors and stockholders approved the OmniComm Systems, Inc. 2016 “2016 2016 2016 10,000,000 2016 2016 January 1st nine (9) January 1, 2017 January 1, 2025, five (5%) 2016 2016 June 29, 2026. The maximum term for any option grant under the 2016 ten 2016 five two first 50% one second second three Any unvested stock options or restricted shares with restrictions that have not lapsed that are granted under the 2016 As of December 31, 2016, 450,000 0 2016 December 31, 2016, 9,550,000 2016 Description of 2009 In 2009, ’s Board of Directors and stockholders approved the 2009 “2009 2009 2009 7,500,000 The maximum term for any option grant under the 2009 ten 2009 five Options granted to employees generally vested either upon grant or in two first 50% one second second 2009 2016 2009 As of December 31, 2016, 775,000 3,893,330 2009 December 31, 2016, 0 2009 The following table summarizes the stock option activity for the Company ’s equity incentive plans: Number of options Weighted average exercise price (per share) Weighted average remaining contractual term (in years) Aggregate intrinsic value Outstanding at December 31, 2014 3,130,000 $ 0.20 1.59 $ 364,900 Granted 225,000 0.25 Exercised (292,500 ) 0.12 Forfeited/cancelled/expired (1,060,000 ) 0.35 Outstanding at December 31, 2015 2,002,500 0.14 1.40 $ 198,990 Granted 450,000 0.20 Exercised (1,120,000 ) 0.12 Forfeited/cancelled/expired (107,500 ) 0.29 Outstanding at December 31, 2016 1,225,000 $ 0.17 2.62 $ 83,425 Vested and exercisable at December 31, 2016 737,500 $ 0.15 1.38 $ 64,550 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company ’s closing stock price at fiscal year-end and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2016. The total number of shares vested and the fair value of shares vested for the years ended December 31, 2016 December 31, 2015, Fair value of options vesting for the year ended Number of options vested Fair value of options vested December 31, 2016 162,500 $ 33,622 December 31, 2015 200,000 $ 34,665 Cash received from stock option exercises for the years ended December 31, 2016 December 31, 2015 $129,500 $27,250, December 31, 2016 December 31, 2015. The following table summarizes information concerning options outstanding at December 31, 2016: Awards breakdown by price range at December 31, 2016 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 850,000 2.15 $ 0.15 625,000 1.32 $ 0.14 0.21 to 0.29 375,000 3.70 0.23 112,500 1.67 0.21 0.30 to 0.49 -0- 0.00 0.00 -0- 0.00 0.00 0.50 to 0.70 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.70 1,225,000 2.62 $ 0.17 737,500 1.38 $ 0.15 The following table summarizes information concerning options outstanding at December 31, 2015: Awards breakdown by price range at December 31, 2015 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 1,777,500 1.14 $ 0.13 1,652,500 0.93 $ 0.13 0.21 to 0.29 125,000 2.83 0.22 100,000 2.46 0.21 0.30 to 0.49 100,000 4.17 0.30 -0- 0.00 0.00 0.50 to 0.70 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.70 2,002,500 1.40 $ 0.14 1,752,500 1.02 $ 0.13 The weighted average fair value (per share) of options granted during the years ended December 31, 2016 December 31, 2015 $0.19 $0.24, Basis for Fair Value Estimate of Share-Based Payments Based on analysis of its historical volatility, the Company expects that the future volatility of its share price is likely to be similar to the historical volatility the Company experienced since the Company ’s commercialization activities were initiated during the second 2000. 2016 2015. may The Company utilizes the historical data available regarding employee and director exercise activity to calculate an expected life of the options. The table below presents the weighted average expected life in years of options granted under the Plan as described above. The risk-free rate of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant, which corresponds with the expected term of the option granted. The fair value of share-based payments was estimated using the Black Scholes option pricing model with the following assumptions for grants made during the periods indicated. Stock option assumptions for the year ended Stock option assumptions December 31, 2016 December 31, 2015 Risk-free interest rate 1.45% 1.20% Expected dividend yield 0.0% 0.0% Expected volatility 155.5% 183.8% Expected life of options (in years) 5 5 The following table summarizes weighted average grant date fair value activity for the Company incentive stock plans: Weighted average grant date fair value for the year ended December 31, 2016 2015 Stock options granted during the period $ 0.19 $ 0.24 Stock options vested during the period $ 0.21 $ 0.17 Stock options forfeited during the period $ 0.28 $ 0.26 A summary of the status of the Company ’s non-vested shares underlying stock options as of December 31, 2016, December 31, 2016 Shares underlying stock options Weighted average grant date fair value Nonvested shares at 250,000 $ 0.23 Nonvested shares at 487,500 $ 0.20 As of December 31, 2016, $76,846 2.38 |
Note 14 - Income Taxes
Note 14 - Income Taxes | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Income Tax Disclosure [Text Block] | NOTE 1 4 : INCOME TAXES A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate to the income before provision for income taxes is as follows : December 31, 2016 December 31, 2015 Federal statutory rate applied to income/(loss) before income taxes $ 38,740 $ 963,947 Increase/(decrease) in income taxes results from: Current tax expense/(benefit) 1,069 (24,739 ) Nondeductible expenses 1,078,519 (1,451,221 ) Change in deferred assets 41,019 97,580 Change in valuation allowance (1,158,278 ) 389,694 Income tax expense/(benefit) $ 1,069 $ (24,739 ) The components of income tax expense/(benefit) for the year ended: December 31, 2016 December 31, 2015 Current tax expense/(benefit): $ 1,069 $ (24,739 ) Deferred tax expense/(benefit): Bad debt allowance (23,699 ) 26,059 Operating loss carryforward 1,140,957 (513,333 ) Amortization of intangibles 5,482 5,482 Patent litigation settlement 35,538 92,098 1,159,347 (414,433 ) Valuation allowance (1,158,278 ) 389,694 Total tax expense/(benefit) $ 1,069 $ (24,739 ) Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows: December 31, 2016 December 31, 2015 Amortization of intangibles $ 267,253 $ 272,734 Bad debt allowance 66,662 42,963 Patent litigation liability accrual 128,804 164,342 Operating loss carryforwards 19,034,573 20,175,531 Gross deferred tax assets 19,497,292 20,655,570 Valuation allowance (19,497,292 ) (20,655,570 ) Net deferred tax liability/(asset) $ -0- $ -0- The Company has net operating loss carry forwards (NOL) for income tax purposes of $ 35,363,091. 2036 1998. December 31, 2016. December 31, 2016 $1,158,278. three |
Note 15 - Subsequent Events
Note 15 - Subsequent Events | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | NOTE 1 5 : SUBSEQUENT EVENTS Subsequent to December 31, 2016 $400,000 On March 24, 2017 500,000 three four 2017. 2016 $0.25 March 24, 2022. On March 24, 2017 16,668 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2016 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company ’s accounts include those of all its wholly-owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation. |
Use of Estimates, Policy [Policy Text Block] | ESTIMATES IN FINANCIAL STATEMENTS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may |
Reclassification, Policy [Policy Text Block] | RECLASSIFICATIONS Certain reclassifications have been made in the 2015 2016 |
Foreign Currency Transactions and Translations Policy [Policy Text Block] | FOREIGN CURRENCY TRANSLATION The financial statements of the Company ’s foreign subsidiaries are translated in accordance with ASC 830 30, Foreign Currency Matters—Translation of Financial Statements $44,150 December 31, 2016 $122,528 December 31, 2015. |
Revenue Recognition, Policy [Policy Text Block] | REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne , Promasys eClinical Suite ( “EDC Software”). TrialMaster eClinical Suite The Company recognizes revenues when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) (3) (4) The Company operates in one The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four Hosted Application Revenues The Company offers its TrialMaster eClinical Suite Revenues resulting from TrialMaster eClinical Suite three first second third Fees charged and costs incurred for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first third second eClinical Suite Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC Software products with its customers for 3 5 30 45 In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may The Company generates customer support and maintenance revenues from its perpetual license customer base. Professional Services The Company may Subsequent additions or extensions to license terms do not generally include additional professional services. Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the years ended December 31, 2016 December 31, 2015, For the year ended Revenue activity December 31, 2016 December 31, 2015 Set-up fees $ 6,658,987 $ 6,649,762 Change orders 1,212,153 846,464 Maintenance 4,803,171 5,107,764 Software licenses 7,885,023 3,975,549 Professional services 3,843,641 3,145,883 Hosting 1,016,535 985,415 Total $ 25,419,510 $ 20,710,837 |
Cost of Sales, Policy [Policy Text Block] | COST OF GOODS SOLD Cost of goods sold primarily consists of costs related to hosting, maintaining and supporting the Company ’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of goods sold also includes outside service provider costs . |
Cash and Cash Equivalents, Policy [Policy Text Block] | CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 The carrying amount reported in the accompanying consolidated balance sheets approximates fair value. |
Receivables, Policy [Policy Text Block] | ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $179,813 December 31, 2016 $116,834 December 31, 2015. The following table summarizes activity in the Company's allowance for doubtful accounts for the years presented. December 31, 2016 December 31, 2015 Beginning of period $ 116,834 $ 186,085 Bad debt expense 132,767 14,939 Write-offs (69,788 ) (84,190 ) End of period $ 179,813 $ 116,834 |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | CONCENTRATION OF CREDIT RISK Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one may December 31, 2016, $1,237,118 Except as follows, the Company has no significant off balance sheet risk or credit risk concentrations. Financial instruments that subject the Company to potential credit risks are principally cash equivalents and accounts receivable. Concentrated credit risk with respect to accounts receivable is limited to creditworthy customers. The Company's customers are principally located in the United States, Europe and East Asia. The Company is directly affected by the overall financial condition of the pharmaceutical, biotechnology and medical device industries and management believes that credit risk exists and that any credit risk the Company faces has been adequately reserved for as of December 31, 2016. December 31, 2016, One customer accounted for 16% December 31, 2016 $4,167,000, 16% December 31, 2015 $3,237,000. 10% Two customers each individually accounted for approximately 11% December 31, 2016. 16% December 31, 2015. Revenues Accounts receivable For the year ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2016 1 16% 2 21% December 31, 2015 1 16% 3 42% The table below provides revenues from European customers for the years ended December 31, 2016 December 31, 2015, European revenues For the year ended December 31, 2016 December 31, 2015 European revenues % of Total revenues European revenues % of Total revenues $ 2,702,660 11% $ 2,150,096 10% The Company serves all of its hosting customers from third third may |
Property, Plant and Equipment, Policy [Policy Text Block] | PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 3 |
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] | ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations 805”) 350, Intangibles- Goodwill and Other 350”). The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no more for an asset than its replacement or reproduction cost. The market approach estimates value based on what other participants in the market have paid for reasonably similar assets. Although each valuation approach is considered in valuing the assets acquired, the approach ultimately selected is based on the characteristics of the asset and the availability of information. Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may ’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value. |
Revenue Recognition, Deferred Revenue [Policy Text Block] | DEFERRED REVENUE Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may December 31, 2016, $9,539,230 1 5 $7,250,061 twelve |
Advertising Costs, Policy [Policy Text Block] | ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $712,179 December 31, 2016 $635,267 December 31, 2015 |
Research, Development, and Computer Software, Policy [Policy Text Block] | RESEARCH AND PRODUCT DEVELOPMENT EXPENSES Software development costs are included in research and product development and are expensed as incurred. ASC 985.20, 985.20. December 31, 2016 $2,598,962 December 31, 2015 $2,639,577, activities, which include costs associated with the development of our software products and services for our client’s projects and which are primarily comprised of salaries and related expenses for our software developers and consulting fees paid to third costs are primarily included under Salaries, benefits and related taxes in our Statement of Operations. |
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2016 “2016 June 16, 2016. The 2016 10,000,000 2016 January 1st nine (9) January 1, 2017 January 1, 2025, five (5%) 2016 The predecessor plan, the OmniComm Systems, Inc. 2009 “2009 July 10, 2009 June 16, 2016 2016 The 2009 7.5 2009 Each plan is more fully described in “Note 13, ASC 718, ASC 718 ’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value. |
Earnings Per Share, Policy [Policy Text Block] | EARNINGS/(LOSS) PER SHARE The Company accounts for Earnings/(loss) Per Share using ASC 260 – Earnings per Share. Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities. |
Income Tax, Policy [Policy Text Block] | INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, 740 Valuation allowances are established, when necessary, to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. |
New Accounting Pronouncements, Policy [Policy Text Block] | IMPACT OF NEW ACCOUNTING STANDARDS During fiscal 2016, In February 2016, ASU”) No. 2016 02, “Leases (Topic 842)” 2016 02”). 12 December 15, 2019. In March 2016, ASU No. 2016 09, “Compensation – Stock Compensation (Topic 718)”, 2016 09”). December 15, 2016, In March 2016, April 2016, December 2016, 2016 08, Revenue from Contracts with Customers - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) 2016 08”), 2016 10, Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing 2016 10”), 2016 20, Technical Corrections and Improvements to Topic 606, 2016 20”) 2014 09. May 2016, 2016 12, Revenue from Contracts with Customers - Narrow Scope Improvements and Practical Expedients 2014 09, December 15, 2016, Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements. |
Note 2 - Summary of Significa24
Note 2 - Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block] | For the year ended Revenue activity December 31, 2016 December 31, 2015 Set-up fees $ 6,658,987 $ 6,649,762 Change orders 1,212,153 846,464 Maintenance 4,803,171 5,107,764 Software licenses 7,885,023 3,975,549 Professional services 3,843,641 3,145,883 Hosting 1,016,535 985,415 Total $ 25,419,510 $ 20,710,837 |
Allowance for Credit Losses on Financing Receivables [Table Text Block] | December 31, 2016 December 31, 2015 Beginning of period $ 116,834 $ 186,085 Bad debt expense 132,767 14,939 Write-offs (69,788 ) (84,190 ) End of period $ 179,813 $ 116,834 |
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | Revenues Accounts receivable For the year ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable December 31, 2016 1 16% 2 21% December 31, 2015 1 16% 3 42% |
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] | European revenues For the year ended December 31, 2016 December 31, 2015 European revenues % of Total revenues European revenues % of Total revenues $ 2,702,660 11% $ 2,150,096 10% |
Note 3 - Earnings (Loss) Per 25
Note 3 - Earnings (Loss) Per Share (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] | Anti-dilutive security December 31, 2016 December 31, 2015 Preferred stock -0- 3,277,229 Employee stock options 275,000 125,000 Warrants 27,860,000 22,900,000 Convertible notes 15,490,000 -0- Shares issuable for accrued interest 150,016 1,054,081 Total 43,775,016 27,356,310 |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | For the year ended December 31, 2016 December 31, 2015 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 101,880 145,868,227 $ 0.00 $ 2,404,498 96,645,482 $ 0.02 Effect of dilutive securities -0- 294,200 0.00 43,316 16,900,259 0.00 Diluted EPS $ 101,880 146,162,427 $ 0.00 $ 2,447,814 113,545,741 $ 0.02 |
Note 4 - Property and Equipme26
Note 4 - Property and Equipment, Net (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | December 31, 2016 December 31, 2015 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 2,125,067 $ 1,761,879 $ 363,188 $ 2,055,956 $ 1,605,473 $ 450,483 5 Leasehold improvements 114,719 89,789 24,930 91,452 85,895 5,557 5 Computer software 1,925,462 1,720,399 205,063 1,843,483 1,621,492 221,991 3 Office furniture 158,436 114,065 44,371 111,660 105,979 5,681 5 Total $ 4,323,684 $ 3,686,132 $ 637,552 $ 4,102,551 $ 3,418,839 $ 683,712 |
Note 5 - Intangible Assets, N27
Note 5 - Intangible Assets, Net (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule of Finite-Lived Intangible Assets [Table Text Block] | December 31, 2016 December 31, 2015 Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical Suite customer list $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer list 104,163 21,990 82,173 108,051 15,607 92,444 15 Promasys B.V. software code 72,837 46,130 26,707 72,837 31,563 41,274 5 Promasys B.V. URLs/website 52,608 52,608 -0- 54,572 39,413 15,159 3 Total $ 1,622,309 $ 1,513,429 $ 108,880 $ 1,628,161 $ 1,479,284 $ 148,877 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | 2017 $ 21,512 2018 19,084 2019 6,944 2020 6,944 2021 6,944 Thereafter 47,452 Total $ 108,880 |
Note 6 - Accounts Payable and28
Note 6 - Accounts Payable and Accrued Expenses (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] | Account December 31, 2016 December 31, 2015 Accounts payable $ 697,060 $ 515,764 Accrued payroll and related costs 886,334 473,108 Other accrued expenses 431,961 105,562 Accrued interest 107,718 862,836 Total accounts payable and accrued expenses $ 2,123,073 $ 1,957,270 |
Note 7 - Line of Credit, Note29
Note 7 - Line of Credit, Notes Payable and Liquidity (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule of Debt [Table Text Block] | Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2016 Current term Current term 2/29/2016 4/1/2019 12% $ 450,000 $ -0- $ -0- $ -0- $ 450,000 6/30/2016 4/1/2020 10% 420,000 -0- 420,000 -0- -0- 6/30/2016 4/1/2020 12% 372,500 -0- 372,500 -0- -0- Discount on notes payable -0- (455,285 ) -0- (237,664 ) Total $ 1,242,500 $ -0- $ 337,215 $ -0- $ 212,336 Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2015 Current term Current term 4/4/2014 4/1/2017 12% $ 45,000 $ -0- $ 45,000 $ -0- $ -0- 4/4/2014 4/1/2017 12% 137,500 -0- 137,500 -0- -0- 4/4/2014 4/1/2017 10% 120,000 -0- 120,000 -0- -0- 12/1/2014 4/1/2017 10% 300,000 -0- 300,000 -0- -0- 12/1/2014 4/1/2017 12% 90,000 -0- 90,000 -0- -0- 12/1/2014 4/1/2017 12% 100,000 -0- 100,000 -0- -0- 4/1/2015 4/1/2018 12% 20,000 -0- -0- -0- 20,000 Discount on notes payable -0- -0- -0- -0- Total $ 812,500 $ -0- $ 792,500 $ -0- $ 20,000 |
Note 8 - Convertible Notes Pa30
Note 8 - Convertible Notes Payable (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule of Maturities of Long-term Debt [Table Text Block] | 2017 $ 50,000 2018 450,000 2019 -0- 2020 6,550,000 Total $ 7,050,000 |
Convertible Debt [Member] | |
Notes Tables | |
Schedule of Long-term Debt Instruments [Table Text Block] | Principal at Carrying amount Date of Maturity Interest December 31, Short term Long term issuance date rate 2016 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 50,000 $ -0- $ 50,000 $ -0- $ -0- 8/29/2008 4/1/2018 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2020 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2018 12% 200,000 -0- -0- -0- 200,000 12/16/2008 4/1/2020 12% 100,000 -0- -0- -0- 100,000 12/16/2008 4/1/2020 12% 4,055,000 -0- -0- 4,055,000 -0- 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 9/30/2009 4/1/2020 12% 625,000 -0- -0- -0- 625,000 Total $ 7,050,000 $ -0- $ 50,000 $ 5,825,000 $ 1,175,000 Principal at Carrying amount Date of Maturity Interest December 31, Short term Long term issuance date rate 2015 Related Non related Related Non related 3/26/1999 6/30/2004 10% $ 75,000 $ -0- $ 75,000 $ -0- $ -0- 8/29/2008 4/1/2017 10% 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2017 10% 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2017 12% 260,000 -0- -0- -0- 260,000 12/16/2008 4/1/2017 12% 4,055,000 -0- -0- 4,055,000 -0- 12/16/2008 4/1/2018 12% 215,000 -0- -0- -0- 215,000 12/16/2008 4/1/2018 12% 25,000 -0- -0- 25,000 -0- 9/30/2009 4/1/2017 12% 625,000 -0- -0- -0- 625,000 9/30/2009 4/1/2018 12% 100,000 -0- -0- -0- 100,000 Total $ 7,275,000 $ -0- $ 75,000 $ 5,850,000 $ 1,350,000 |
Note 9 - Fair Value Measureme31
Note 9 - Fair Value Measurement (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] | Fair value at Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2016 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Derivatives: (1) (2) Conversion feature liability $ 2,325,730 $ -0- $ -0- $ 2,325,730 Warrant liability 3,999,362 -0- -0- 3,999,362 Total of derivative liabilities $ 6,325,092 $ -0- $ -0- $ 6,325,092 Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs December 31, 2015 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 901,243 $ -0- $ -0- $ 901,243 Warrant liability 1,914,923 -0- -0- 1,914,923 Total of derivative liabilities $ 2,816,166 $ -0- $ -0- $ 2,816,166 |
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] | Significant valuation assumptions for derivative instruments at December 31, 2016 Risk free interest rate 0.82% to 1.45% Dividend yield 0.00% Expected volatility 117.3% to 143.8% Expected life (range in years) Conversion feature liability 1.25 to 3.25 Warrant liability 0.25 to 3.25 Significant valuation assumptions for derivative instruments at December 31, 2015 Risk free interest rate 0.48% to 1.2% Dividend yield 0.00% Expected volatility 91.0% to 132.2% Expected life (range in years) Conversion feature liability 1.25 to 2.25 Warrant liability 0.00 to 3.01 |
Fair Value Measurements, Nonrecurring [Table Text Block] | Carrying amount Carrying amount Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2015 December 31, 2016 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 92,444 $ 82,173 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 41,274 26,707 -0- -0- 72,943 Promasys B.V. URLs/website (4) 15,159 -0- -0- -0- 68,814 Total $ 148,877 $ 108,880 $ -0- $ -0- $ 278,010 Carrying Amount Carrying Amount Quoted prices in active markets for identical assets/ Significant other observable Significant unobservable December 31, 2014 December 31, 2015 liabilities (Level 1) inputs (Level 2) inputs (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 110,948 $ 92,444 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 55,842 41,274 -0- -0- 72,943 Promasys B.V. URLs/website (4) 37,131 15,159 -0- -0- 68,814 Total $ 203,921 $ 148,877 $ -0- $ -0- $ 278,010 |
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block] | Other income/(expense) For the year ended December 31, 2016 December 31, 2015 The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date $ (2,657,910 ) $ 4,525,798 Total unrealized and realized gains/(losses) included in earnings $ (2,657,910 ) $ 4,525,798 |
Schedule of Derivative Liabilities at Fair Value [Table Text Block] | Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2016 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (901,243 ) $ 29,108 $ (1,453,595 ) $ -0- $ -0- $ (2,325,730 ) Warrant liability (1,914,923 ) -0- (1,233,423 ) (851,016 ) -0- (3,999,362 ) Total of derivative liabilities $ (2,816,166 ) $ 29,108 $ (2,687,018 ) $ (851,016 ) $ -0- $ (6,325,092 ) Level 3 financial liabilities at fair value Net purchases, Balance, issuances Balance, For the year ended beginning Net realized Net unrealized and Net transfers end December 31, 2015 of year gains/(losses) gains/(losses) settlements in and/or out of year Derivatives: Conversion feature liability $ (2,944,402 ) $ 29,875 $ 2,013,284 $ -0- $ -0- $ (901,243 ) Warrant liability (6,695,060 ) -0- 2,482,639 (868,128 ) 3,165,626 (1,914,923 ) Total of derivative liabilities $ (9,639,462 ) $ 29,875 $ 4,495,923 $ (868,128 ) $ 3,165,626 $ (2,816,166 ) |
Note 10 - Commitments and Con32
Note 10 - Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule Of Minimum Royalty Payments [Table Text Block] | 2017 $ 655,832 2018 512,157 2019 421,230 2020 297,570 2021 269,962 Thereafter 310,550 Total $ 2,467,301 |
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] | 2017 $ 450,000 2018 164,500 Total $ 614,500 |
Note 12 - Stockholders' (Defi33
Note 12 - Stockholders' (Deficit) (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule Of Dividends In Arrears [Table Text Block] | Cumulative arrearage as of Cumulative arrearage per share as of December 31, December 31, Series of preferred stock 2016 2015 2016 2015 Series A $ -0- $ 2,465,830 $ -0- $ 0.68 Series B 609,887 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 2,081,980 $ 4,547,810 |
Schedule of Dividends Payable [Table Text Block] | Dividends accreted Dividends per share For the year ended For the year ended December 31, December 31, 2016 2015 2016 2015 Preferred stock dividends in arrears Series A $ -0- $ 181,886 $ -0- $ 0.050 Preferred stock dividends in arrears Series B $ -0- $ -0- $ -0- $ -0- Preferred stock dividends in arrears Series C $ -0- $ -0- $ -0- $ -0- |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | December 31, 2016 December 31, 2016 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 - $0.60 27,860,000 2.71 $ 0.42 27,860,000 $ 0.42 December 31, 2015 December 31, 2015 Warrants outstanding Warrants exercisable Weighted average Weighted average Weighted average Range of exercise price Number outstanding remaining contractual life exercise price Number exercisable exercise price $0.25 - $0.60 22,900,000 1.76 $ 0.46 22,900,000 $ 0.46 |
Schedule of Share-based Compensation, Activity [Table Text Block] | Weighted average grant date fair value for the year ended December 31, 2016 2015 Stock options granted during the period $ 0.19 $ 0.24 Stock options vested during the period $ 0.21 $ 0.17 Stock options forfeited during the period $ 0.28 $ 0.26 |
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Foreign currency translation Accumulated other comprehensive (loss) Balance at December 31, 2014 $ (243,827 ) $ (243,827 ) 2015 Activity (122,528 ) (122,528 ) Balance at December 31, 2015 (366,355 ) (366,355 ) 2016 Activity (44,150 ) (44,150 ) Balance at December 31, 2016 $ (410,505 ) $ (410,505 ) |
Warrant [Member] | |
Notes Tables | |
Schedule of Share-based Compensation, Activity [Table Text Block] | Warrants Balance at December 31, 2014 48,463,517 Issued 3,800,000 Exercised -0- Cancelled (29,363,517 ) Expired/forfeited -0- Balance at December 31, 2015 22,900,000 Issued 4,970,000 Exercised -0- Expired/forfeited (10,000 ) Balance at December 31, 2016 27,860,000 Warrants exercisable at December 31, 2016 27,860,000 Weighted average fair value of warrants granted during 2016 $ 0.16 |
Note 13 - Employee Equity Inc34
Note 13 - Employee Equity Incentive Plans (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | Number of options Weighted average exercise price (per share) Weighted average remaining contractual term (in years) Aggregate intrinsic value Outstanding at December 31, 2014 3,130,000 $ 0.20 1.59 $ 364,900 Granted 225,000 0.25 Exercised (292,500 ) 0.12 Forfeited/cancelled/expired (1,060,000 ) 0.35 Outstanding at December 31, 2015 2,002,500 0.14 1.40 $ 198,990 Granted 450,000 0.20 Exercised (1,120,000 ) 0.12 Forfeited/cancelled/expired (107,500 ) 0.29 Outstanding at December 31, 2016 1,225,000 $ 0.17 2.62 $ 83,425 Vested and exercisable at December 31, 2016 737,500 $ 0.15 1.38 $ 64,550 |
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block] | Fair value of options vesting for the year ended Number of options vested Fair value of options vested December 31, 2016 162,500 $ 33,622 December 31, 2015 200,000 $ 34,665 |
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] | Awards breakdown by price range at December 31, 2016 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 850,000 2.15 $ 0.15 625,000 1.32 $ 0.14 0.21 to 0.29 375,000 3.70 0.23 112,500 1.67 0.21 0.30 to 0.49 -0- 0.00 0.00 -0- 0.00 0.00 0.50 to 0.70 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.70 1,225,000 2.62 $ 0.17 737,500 1.38 $ 0.15 Awards breakdown by price range at December 31, 2015 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 1,777,500 1.14 $ 0.13 1,652,500 0.93 $ 0.13 0.21 to 0.29 125,000 2.83 0.22 100,000 2.46 0.21 0.30 to 0.49 100,000 4.17 0.30 -0- 0.00 0.00 0.50 to 0.70 -0- 0.00 0.00 -0- 0.00 0.00 0.00 to 0.70 2,002,500 1.40 $ 0.14 1,752,500 1.02 $ 0.13 |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | Stock option assumptions for the year ended Stock option assumptions December 31, 2016 December 31, 2015 Risk-free interest rate 1.45% 1.20% Expected dividend yield 0.0% 0.0% Expected volatility 155.5% 183.8% Expected life of options (in years) 5 5 |
Schedule of Share-based Compensation, Activity [Table Text Block] | Weighted average grant date fair value for the year ended December 31, 2016 2015 Stock options granted during the period $ 0.19 $ 0.24 Stock options vested during the period $ 0.21 $ 0.17 Stock options forfeited during the period $ 0.28 $ 0.26 |
Schedule of Nonvested Share Activity [Table Text Block] | Shares underlying stock options Weighted average grant date fair value Nonvested shares at 250,000 $ 0.23 Nonvested shares at 487,500 $ 0.20 |
Note 14 - Income Taxes (Tables)
Note 14 - Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Notes Tables | |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | December 31, 2016 December 31, 2015 Federal statutory rate applied to income/(loss) before income taxes $ 38,740 $ 963,947 Increase/(decrease) in income taxes results from: Current tax expense/(benefit) 1,069 (24,739 ) Nondeductible expenses 1,078,519 (1,451,221 ) Change in deferred assets 41,019 97,580 Change in valuation allowance (1,158,278 ) 389,694 Income tax expense/(benefit) $ 1,069 $ (24,739 ) |
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] | December 31, 2016 December 31, 2015 Current tax expense/(benefit): $ 1,069 $ (24,739 ) Deferred tax expense/(benefit): Bad debt allowance (23,699 ) 26,059 Operating loss carryforward 1,140,957 (513,333 ) Amortization of intangibles 5,482 5,482 Patent litigation settlement 35,538 92,098 1,159,347 (414,433 ) Valuation allowance (1,158,278 ) 389,694 Total tax expense/(benefit) $ 1,069 $ (24,739 ) |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | December 31, 2016 December 31, 2015 Amortization of intangibles $ 267,253 $ 272,734 Bad debt allowance 66,662 42,963 Patent litigation liability accrual 128,804 164,342 Operating loss carryforwards 19,034,573 20,175,531 Gross deferred tax assets 19,497,292 20,655,570 Valuation allowance (19,497,292 ) (20,655,570 ) Net deferred tax liability/(asset) $ -0- $ -0- |
Note 1 - Organization and Nat36
Note 1 - Organization and Nature of Operations (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Research and Development Expense | $ 2,598,962 | $ 2,639,577 |
Note 2 - Summary of Significa37
Note 2 - Summary of Significant Accounting Policies (Details Textual) | 12 Months Ended | ||
Dec. 31, 2016USD ($)shares | Dec. 31, 2015USD ($) | Jul. 10, 2009shares | |
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | $ (44,150) | $ (122,528) | |
Number of Reportable Segments | 1 | ||
Number of Revenue Producing Activities | 4 | ||
Allowance for Doubtful Accounts Receivable, Current | $ 179,813 | 116,834 | |
Cash, Uninsured Amount | 1,237,118 | ||
Revenues | $ 25,419,510 | 20,710,837 | |
Property, Plant and Equipment, Useful Life | |||
Deferred Revenue | $ 9,539,230 | ||
Deferred Revenue, Current | 7,250,061 | 7,054,614 | |
Advertising Expense | 712,179 | 635,267 | |
Research and Development Expense | $ 2,598,962 | $ 2,639,577 | |
The 2016 Plan [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 10,000,000 | ||
Common Stock Available for Issuance Increasing Period | 9 years | ||
Common Stock Available for Issuance, Annual Increase Percent | 5.00% | ||
Plan 2009 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 7,500,000 | ||
Leasehold Improvements Computers Equipment And Furniture [Member] | |||
Property, Plant and Equipment, Useful Life | 5 years | ||
Software Development [Member] | |||
Property, Plant and Equipment, Useful Life | 3 years | ||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | |||
Concentration Risk, Percentage | 16.00% | 16.00% | |
Accounts Receivable [Member] | Customer Concentration Risk [Member] | |||
Concentration Risk, Percentage | 21.00% | 42.00% | |
Customer 1 [Member] | Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | |||
Concentration Risk, Percentage | 16.00% | 16.00% | |
Revenues | $ 4,167,000 | $ 3,237,000 | |
Customer 1 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member] | |||
Concentration Risk, Percentage | 11.00% | 16.00% | |
Customer 2 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member] | |||
Concentration Risk, Percentage | 11.00% | ||
Minimum [Member] | |||
Term Of Software License | 3 years | ||
Deferred Revenue, Service Contract Term | 30 days | ||
Maximum [Member] | |||
Term Of Software License | 5 years | ||
Deferred Revenue, Service Contract Term | 5 years |
Note 2 - Summary of Significa38
Note 2 - Summary of Significant Accounting Policies - Revenue by Business Activity (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Revenues | $ 25,419,510 | $ 20,710,837 |
Set Up Fees [Member] | ||
Revenues | 6,658,987 | 6,649,762 |
Change Orders [Member] | ||
Revenues | 1,212,153 | 846,464 |
Maintenance [Member] | ||
Revenues | 4,803,171 | 5,107,764 |
Software Licenses [Member] | ||
Revenues | 7,885,023 | 3,975,549 |
Professional Services [Member] | ||
Revenues | 3,843,641 | 3,145,883 |
Hosting [Member] | ||
Revenues | $ 1,016,535 | $ 985,415 |
Note 2 - Summary of Significa39
Note 2 - Summary of Significant Accounting Policies - Allowance for Doubtful Account Summary (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Beginning of period | $ 116,834 | $ 186,085 |
Bad debt expense | 132,767 | 14,939 |
Write-offs | (69,788) | (84,190) |
End of period | $ 179,813 | $ 116,834 |
Note 2 - Summary of Significa40
Note 2 - Summary of Significant Accounting Policies - Customer Concentration (Details) - Customer Concentration Risk [Member] | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Sales Revenue, Net [Member] | ||
Number of customers | 1 | 1 |
Concentration risk, percentage | 16.00% | 16.00% |
Accounts Receivable [Member] | ||
Number of customers | 2 | 3 |
Concentration risk, percentage | 21.00% | 42.00% |
Note 2 - Summary of Significa41
Note 2 - Summary of Significant Accounting Policies - Revenue From European Operations (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
European revenues | $ 25,419,510 | $ 20,710,837 |
Reportable Geographical Components [Member] | Europe [Member] | ||
European revenues | $ 2,702,660 | $ 2,150,096 |
Concentration risk, percentage | 11.00% | 10.00% |
Note 3 - Earnings (Loss) Per 42
Note 3 - Earnings (Loss) Per Share (Details Textual) - $ / shares | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Weighted Average Number of Shares Outstanding, Basic | 145,868,227 | 96,645,482 |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 43,775,016 | 27,356,310 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ 0.15 | |
Lower Range Limit [Member] | ||
Debt Instrument, Convertible, Conversion Price | 0.25 | |
Upper Range Limit [Member] | ||
Debt Instrument, Convertible, Conversion Price | 0.50 | |
Lower Range Limit [Member] | ||
Investment Warrants, Exercise Price | 0.25 | |
Upper Range Limit [Member] | ||
Investment Warrants, Exercise Price | 0.60 | |
Minimum [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | 0.045 | |
Maximum [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ 0.24 |
Note 3 - Earnings (Loss) Per 43
Note 3 - Earnings (Loss) Per Share - Reconciliation of Anti-dilutive Securities (Details) - shares | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Anti-dilutive Security (in shares) | 43,775,016 | 27,356,310 |
Shares Of Preferred Stock [Member] | ||
Anti-dilutive Security (in shares) | 0 | 3,277,229 |
Employee Stock Option [Member] | ||
Anti-dilutive Security (in shares) | 275,000 | 125,000 |
Warrant [Member] | ||
Anti-dilutive Security (in shares) | 27,860,000 | 22,900,000 |
Convertible Debt Securities [Member] | ||
Anti-dilutive Security (in shares) | 15,490,000 | 0 |
Shares Issuable For Accrued Interest [Member] | ||
Anti-dilutive Security (in shares) | 150,016 | 1,054,081 |
Note 3 - Earnings (Loss) Per 44
Note 3 - Earnings (Loss) Per Share - Computation of Diluted Earnings Per Share (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Basic EPS, Income (loss) numerator | $ 101,880 | $ 2,404,498 |
Weighted Average Number of Shares Outstanding, Basic | 145,868,227 | 96,645,482 |
Basic EPS, Per-share amount (in dollars per share) | $ 0 | $ 0.02 |
Effect of dilutive securities, Income (loss) numerator | $ 0 | $ 43,316 |
Effect of dilutive securities, Shares denominator (in shares) | 294,200 | 16,900,259 |
Effect of dilutive securities, Per-share amount (in dollars per share) | $ 0 | $ 0 |
Diluted EPS, Income (loss) numerator | $ 101,880 | $ 2,447,814 |
Diluted EPS, Shares denominator (in shares) | 146,162,427 | 113,545,741 |
Diluted EPS (in dollars per share) | $ 0 | $ 0.02 |
Note 4 - Property and Equipme45
Note 4 - Property and Equipment, Net (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Depreciation | $ 302,893 | $ 233,798 |
Note 4 - Property and Equipme46
Note 4 - Property and Equipment, Net - Property and Equipment (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Cost | $ 4,323,684 | $ 4,102,551 |
Accumulated Depreciation | 3,686,132 | 3,418,839 |
Net Book Value | $ 637,552 | 683,712 |
Estimated Useful Lives (Year) | ||
Computer And Office Equipment [Member] | ||
Cost | $ 2,125,067 | 2,055,956 |
Accumulated Depreciation | 1,761,879 | 1,605,473 |
Net Book Value | $ 363,188 | 450,483 |
Estimated Useful Lives (Year) | 5 years | |
Leasehold Improvements [Member] | ||
Cost | $ 114,719 | 91,452 |
Accumulated Depreciation | 89,789 | 85,895 |
Net Book Value | $ 24,930 | 5,557 |
Estimated Useful Lives (Year) | 5 years | |
Computer Equipment [Member] | ||
Cost | $ 1,925,462 | 1,843,483 |
Accumulated Depreciation | 1,720,399 | 1,621,492 |
Net Book Value | $ 205,063 | 221,991 |
Estimated Useful Lives (Year) | 3 years | |
Furniture and Fixtures [Member] | ||
Cost | $ 158,436 | 111,660 |
Accumulated Depreciation | 114,065 | 105,979 |
Net Book Value | $ 44,371 | $ 5,681 |
Estimated Useful Lives (Year) | 5 years |
Note 5 - Intangible Assets, N47
Note 5 - Intangible Assets, Net (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Amortization of Intangible Assets | $ 37,331 | $ 40,338 |
Note 5 - Intangible Assets, N48
Note 5 - Intangible Assets, Net - Intangible Assets (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Cost | $ 1,622,309 | $ 1,628,161 |
Accumulated amortization | 1,513,429 | 1,479,284 |
Net Book Value | 108,880 | 148,877 |
eClinical Customer List [Member] | ||
Cost | 1,392,701 | 1,392,701 |
Accumulated amortization | 1,392,701 | 1,392,701 |
Net Book Value | $ 0 | 0 |
Finite-Lived Intangible Asset, Useful Life | 3 years | |
Promasys B.V. Customer List [Member] | ||
Cost | $ 104,163 | 108,051 |
Accumulated amortization | 21,990 | 15,607 |
Net Book Value | $ 82,173 | 92,444 |
Finite-Lived Intangible Asset, Useful Life | 15 years | |
Promasys B.V. Software Code [Member] | ||
Cost | $ 72,837 | 72,837 |
Accumulated amortization | 46,130 | 31,563 |
Net Book Value | $ 26,707 | 41,274 |
Finite-Lived Intangible Asset, Useful Life | 5 years | |
Promasys B.V. URLs/Website [Member] | ||
Cost | $ 52,608 | 54,572 |
Accumulated amortization | 52,608 | 39,413 |
Net Book Value | $ 0 | $ 15,159 |
Finite-Lived Intangible Asset, Useful Life | 3 years |
Note 5 - Intangible Assets, N49
Note 5 - Intangible Assets, Net - Intangible Assets, Future Amortization Expense (Details) | Dec. 31, 2016USD ($) |
2,017 | $ 21,512 |
2,018 | 19,084 |
2,019 | 6,944 |
2,020 | 6,944 |
2,021 | 6,944 |
Thereafter | 47,452 |
Total | $ 108,880 |
Note 6 - Accounts Payable and50
Note 6 - Accounts Payable and Accrued Expenses - Accounts Payable and Accrued Expenses (Details) - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
Accounts payable | $ 697,060 | $ 515,764 |
Accrued payroll and related costs | 886,334 | 473,108 |
Other accrued expenses | 431,961 | 105,562 |
Accrued interest | 107,718 | 862,836 |
Total accounts payable and accrued expenses | $ 2,123,073 | $ 1,957,270 |
Note 7 - Line of Credit, Note51
Note 7 - Line of Credit, Notes Payable and Liquidity (Details Textual) - USD ($) | Dec. 14, 2016 | Dec. 05, 2016 | Jun. 30, 2016 | Feb. 29, 2016 | Dec. 17, 2015 | Nov. 23, 2015 | Nov. 19, 2015 | Oct. 15, 2015 | Jan. 31, 2015 | Mar. 18, 2013 | Dec. 31, 2016 | Dec. 31, 2015 | Apr. 01, 2015 | Feb. 03, 2015 | Dec. 18, 2013 |
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,000,000 | $ 5,000,000 | $ 4,000,000 | ||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | ||||||||||||||
Debt Instrument, Periodic Payment, Interest | $ 9,500 | ||||||||||||||
Long-term Line of Credit | $ 2,700,000 | ||||||||||||||
Line of Credit Facility, Interest Rate at Period End | 2.75% | ||||||||||||||
Unsecured Debt | $ 1,242,500 | $ 812,500 | |||||||||||||
Debt Instrument, Face Amount | $ 7,050,000 | $ 7,275,000 | |||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 0 | $ 1,915,000 | |||||||||||||
Class of Warrant or Right Cancelled During the Period | 29,363,517 | ||||||||||||||
Chief Executive Officer and Director Mr. Wit [Member] | |||||||||||||||
Repayments of Long-term Debt | $ 6,879 | ||||||||||||||
Class of Warrant or Right Cancelled During the Period | 11,440,000 | ||||||||||||||
Chief Executive Officer and Director Mr. Wit [Member] | Related Warrants [Member] | |||||||||||||||
Warrants Sold During the Period | 2,000,000 | 4,000,000 | |||||||||||||
Class of Warrant or Right Cancelled During the Period | 400,000 | ||||||||||||||
Chief Executive Officer and Director Mr. Wit [Member] | Unrelated Warrants [Member] | |||||||||||||||
Class of Warrant or Right Cancelled During the Period | 6,000,000 | ||||||||||||||
Chief Executive Officer and Director Mr. Wit [Member] | Matures On January 1, 2019 III [Member] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 529,000 | ||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | 2,116,000 | ||||||||||||||
Chief Executive Officer and Director Mr. Wit [Member] | Matures on January 1, 2019 [Member] | |||||||||||||||
Debt Conversion, Converted Instrument, Rate | 12.00% | ||||||||||||||
Chief Executive Officer and Director Mr. Wit [Member] | Matures On January 1, 2019 IV [Member] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 2,860,000 | ||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | 11,440,000 | ||||||||||||||
Chief Executive Officer and Director Mr. Wit [Member] | Matures On January 1, 2019 V [Member] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 950,000 | ||||||||||||||
Debt Conversion, Converted Instrument, Rate | 12.00% | ||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | 3,800,000 | ||||||||||||||
Matures on April 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||
Debt Instrument, Face Amount | $ 450,000 | ||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,800,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||||||||
Extinguishment of Debt, Amount | $ 450,000 | ||||||||||||||
Warrants Sold During the Period | 1,000,000 | ||||||||||||||
Warrants and Rights Outstanding | 325,689 | ||||||||||||||
Debt Instrument, Fair Value Disclosure | $ 124,311 | ||||||||||||||
Amortization Period of Warrant Liabilities | 3 years 30 days | ||||||||||||||
Matures April 1, 2020 I [Member] | Investor [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||
Debt Instrument, Face Amount | $ 372,500 | ||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,490,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||||||||
Warrants and Rights Outstanding | $ 246,921 | ||||||||||||||
Debt Instrument, Fair Value Disclosure | $ 125,579 | ||||||||||||||
Amortization Period of Warrant Liabilities | 3 years 270 days | ||||||||||||||
Repayments of Debt | $ 90,000 | ||||||||||||||
Matures April 1, 2020 II [Member] | Investor [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||||||
Debt Instrument, Face Amount | $ 420,000 | ||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,680,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||||||||
Warrants and Rights Outstanding | $ 278,408 | ||||||||||||||
Debt Instrument, Fair Value Disclosure | $ 141,592 | ||||||||||||||
Amortization Period of Warrant Liabilities | 3 years 270 days | ||||||||||||||
Note Payable 14 [Member] | Chief Executive Officer and Director Mr. Wit [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||
Debt Instrument, Face Amount | $ 529,000 | ||||||||||||||
Debt Conversion, Converted Instrument, Rate | 12.00% | ||||||||||||||
Note Payable 15 [Member] | Chief Executive Officer and Director Mr. Wit [Member] | |||||||||||||||
Debt Instrument, Face Amount | $ 2,860,000 | ||||||||||||||
Note Payable 16 [Member] | Chief Executive Officer and Director Mr. Wit [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||
Debt Instrument, Face Amount | $ 950,000 | ||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 3,800,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | ||||||||||||||
Debt Instrument, Repurchase Amount | $ 280,000 | ||||||||||||||
Interest Payable | $ 670,000 | ||||||||||||||
Note Payable 17 [Member] | Chairman and Chief Technology Officer [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||
Debt Instrument, Face Amount | $ 20,000 | ||||||||||||||
Matures on January 1, 2019 [Member] | Chief Executive Officer and Director Mr. Wit [Member] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 980,000 | ||||||||||||||
Debt Conversion, Converted Instrument, Rate | 12.00% | ||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | 3,920,000 | ||||||||||||||
Matures On January 1, 2019 II [Member] | Chief Executive Officer and Director Mr. Wit [Member] | |||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 1,600,000 | ||||||||||||||
Debt Conversion, Converted Instrument, Rate | 12.00% | ||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | 6,400,000 |
Note 7 - Line of Credit, Note52
Note 7 - Line of Credit, Notes Payable and Liquidity - Notes Payable (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2016 | Dec. 31, 2015 | Mar. 18, 2013 | |
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | ||
Ending principal | $ 1,242,500 | $ 812,500 | |
Discount on notes payable | |||
Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | 0 | |
Discount on notes payable | 0 | 0 | |
Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | 0 | |
Discount on notes payable | 0 | 0 | |
Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 337,215 | 792,500 | |
Discount on notes payable | (455,285) | 0 | |
Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | 212,336 | 20,000 | |
Discount on notes payable | $ (237,664) | $ 0 | |
Notes Payable, Matures April 1, 2019 [Member] | |||
Maturity date | Apr. 1, 2019 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Ending principal | $ 450,000 | ||
Notes Payable, Matures April 1, 2019 [Member] | Short-term Debt [Member] | Non-Related Party Current [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2019 [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2019 [Member] | Long-term Debt [Member] | Non-Related Party Current [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2019 [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 450,000 | ||
Notes Payable, Matures April 1, 2017 [Member] | |||
Maturity date | Apr. 1, 2017 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Ending principal | $ 45,000 | ||
Notes Payable, Matures April 1, 2017 [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 45,000 | ||
Notes Payable, Matures April 1, 2017 [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | ||
Notes Payable, Matures April 1, 2020 I [Member] | |||
Maturity date | Apr. 1, 2020 | ||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||
Ending principal | $ 420,000 | ||
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2020 I [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 420,000 | ||
Notes Payable, Matures April 1, 2020 I [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | ||
Notes Payable, Matures April 1, 2017 II [Member] | |||
Maturity date | Apr. 1, 2017 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Ending principal | $ 137,500 | ||
Notes Payable, Matures April 1, 2017 II [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 II [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 II [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 137,500 | ||
Notes Payable, Matures April 1, 2017 II [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | ||
Notes Payable, Matures April 1, 2020 II [Member] | |||
Maturity date | Apr. 1, 2020 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Ending principal | $ 372,500 | ||
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2020 II [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 372,500 | ||
Notes Payable, Matures April 1, 2020 II [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | ||
Notes Payable, Matures April 1, 2017 III [Member] | |||
Maturity date | Apr. 1, 2017 | ||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||
Ending principal | $ 120,000 | ||
Notes Payable, Matures April 1, 2017 III [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 III [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 III [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 120,000 | ||
Notes Payable, Matures April 1, 2017 III [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | ||
Notes Payable, Matures April 1, 2017 IV [Member] | |||
Maturity date | Apr. 1, 2017 | ||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||
Ending principal | $ 300,000 | ||
Notes Payable, Matures April 1, 2017 IV [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 IV [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 IV [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 300,000 | ||
Notes Payable, Matures April 1, 2017 IV [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | ||
Notes Payable, Matures April 1, 2017 V [Member] | |||
Maturity date | Apr. 1, 2017 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Ending principal | $ 90,000 | ||
Notes Payable, Matures April 1, 2017 V [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 V [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 V [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 90,000 | ||
Notes Payable, Matures April 1, 2017 V [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | ||
Notes Payable, Matures April 1, 2017 VI [Member] | |||
Maturity date | Apr. 1, 2017 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Ending principal | $ 100,000 | ||
Notes Payable, Matures April 1, 2017 VI [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 VI [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2017 VI [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 100,000 | ||
Notes Payable, Matures April 1, 2017 VI [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 0 | ||
Notes Payable, Matures April 1, 2018 [Member] | |||
Maturity date | Apr. 1, 2018 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Ending principal | $ 20,000 | ||
Notes Payable, Matures April 1, 2018 [Member] | Short-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2018 [Member] | Short-term Debt [Member] | Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2018 [Member] | Long-term Debt [Member] | Non-Related Party [Member] | |||
Ending principal | 0 | ||
Notes Payable, Matures April 1, 2018 [Member] | Long-term Debt [Member] | Related Party [Member] | |||
Ending principal | $ 20,000 |
Note 8 - Convertible Notes Pa53
Note 8 - Convertible Notes Payable (Details Textual) - USD ($) | Nov. 23, 2015 | Nov. 19, 2015 | May 01, 2015 | Mar. 30, 2011 | Sep. 30, 2009 | Dec. 31, 1999 | Aug. 29, 2008 | Dec. 31, 2016 | Dec. 31, 2015 | Jun. 30, 2016 | Feb. 29, 2016 | Jun. 30, 2015 | May 07, 2015 | Apr. 30, 2015 | Apr. 27, 2015 | Apr. 02, 2015 | Apr. 01, 2015 | Jan. 31, 2015 | Jul. 31, 2014 | Apr. 28, 2014 | Apr. 21, 2014 | Dec. 31, 2013 | Mar. 18, 2013 | Mar. 12, 2013 | Mar. 06, 2013 | Feb. 27, 2013 | Feb. 22, 2013 | Sep. 30, 2011 | Dec. 31, 2009 | Dec. 16, 2008 | Jun. 30, 2008 | Jun. 30, 2004 |
Convertible Notes Payable | $ 0 | $ 0 | ||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 0 | $ 1,915,000 | ||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | ||||||||||||||||||||||||||||||||
Repayments of Notes Payable | $ 245,000 | $ 75,000 | ||||||||||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | 29,363,517 | |||||||||||||||||||||||||||||||
Chief Executive Officer and Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | 11,440,000 | |||||||||||||||||||||||||||||||
Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | |||||||||||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | 1,900,000 | |||||||||||||||||||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | 37,023,517 | |||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | ||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Interest Payable | $ 450,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,800,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | |||||||||||||||||||||||||||||||
Convertible Notes 10% [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 862,500 | |||||||||||||||||||||||||||||||
Payments of Debt Issuance Costs | 119,625 | |||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 742,875 | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 1.25 | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 812,500 | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 1,495,179 | |||||||||||||||||||||||||||||||
Long-term Debt, Gross | $ 50,000 | |||||||||||||||||||||||||||||||
Interest Payable | $ 88,210 | |||||||||||||||||||||||||||||||
Secured Convertible Debenture [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 1,400,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Proceeds from Issuance of Secured Debt | $ 1,400,000 | |||||||||||||||||||||||||||||||
Repayments of Notes Payable | $ 200,000 | |||||||||||||||||||||||||||||||
Secured Convertible Debenture [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | 1,200,000 | |||||||||||||||||||||||||||||||
Secured Convertible Debenture [Member] | Chief Executive Officer and Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 1,100,000 | $ 1,100,000 | ||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.25 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 5,600,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | |||||||||||||||||||||||||||||||
Secured Convertible Debenture [Member] | Chief Executive Officer and Director Mr. Wit [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 1,100,000 | |||||||||||||||||||||||||||||||
Secured Convertible Debenture [Member] | Lenders [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 625,000 | $ 100,000 | 1,200,000 | |||||||||||||||||||||||||||||
Secured Convertible Debenture [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 475,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,900,000 | |||||||||||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 475,000 | |||||||||||||||||||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | 1,900,000 | |||||||||||||||||||||||||||||||
Increase (Decrease) in Notes Payable, Related Parties | $ 625,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 2,270,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | 1,770,000 | 1,770,000 | ||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | ||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.50 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 4,540,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Mr. van Kesteren and Mr. Wit [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 1,920,000 | 150,000 | ||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Non-Related Party [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 150,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued August 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures 2 [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 150,000 | |||||||||||||||||||||||||||||||
Convertible Debentures [Member] | Lenders [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 1,440,000 | |||||||||||||||||||||||||||||||
Convertible Debentures [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 510,000 | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 510,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 5,760,000 | |||||||||||||||||||||||||||||||
Convertible Debentures [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 150,000 | |||||||||||||||||||||||||||||||
Convertible Debentures [Member] | Chief Operating Officer [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 25,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Matures April 1, 2020 I [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | 4,055,000 | |||||||||||||||||||||||||||||||
Matures April 1, 2020 I [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures 2 [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | 1,770,000 | |||||||||||||||||||||||||||||||
Notes Payable, Matures April 1, 2018 [Member] | ||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | 160,000 | |||||||||||||||||||||||||||||||
Notes Payable, Matures April 1, 2018 [Member] | Chief Officer, Mr. Wit and Mr. Van Kesteren [Member] | Extended Maturity Debentures 2 [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | 150,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 5,075,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Non-Related Party [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 160,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 360,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Lenders [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 100,000 | $ 200,000 | ||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | ||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Lenders [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 100,000 | $ 100,000 | $ 200,000 | 4,505,000 | ||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 1,680,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | 1,680,000 | |||||||||||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 420,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 4,475,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 160,000 | $ 160,000 | ||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer, Director, Chief Operating Officer, Chairman, Chief Technology Officer, Chief Financial Officer and Directors [Member] | ||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.50 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 10,150,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Officers, Directors and Affiliate [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 4,980,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Executive Officer [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | 4,475,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chief Operating Officer [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | 25,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Chairman and Chief Technology Officer [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 5,000 | 5,000 | ||||||||||||||||||||||||||||||
Related Party Transaction, Amounts of Transaction | $ 5,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Former Director [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 15,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | Former Director [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 15,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2008 [Member] | President [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 25,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Matures April 1, 2020 II [Member] | Lenders [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 100,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2009 [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 1,490,000 | |||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 0.25 | |||||||||||||||||||||||||||||||
Extinguishment of Debt, Amount | 1,440,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2009 [Member] | Chief Executive Officer and Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 5,960,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.25 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2009 [Member] | Lenders [Member] | Extended Maturity Debentures [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 50,000 | $ 1,490,000 | ||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2009 [Member] | Lenders [Member] | Extended Maturity Debentures 2 [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 1,490,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2009 [Member] | Director Mr. Wit [Member] | ||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 1,440,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 5,760,000 | |||||||||||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | 5,760,000 | |||||||||||||||||||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | 5,760,000 | |||||||||||||||||||||||||||||||
Convertible Debentures Issued December 2009 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures 2 [Member] | ||||||||||||||||||||||||||||||||
Convertible Notes Payable | $ 1,440,000 |
Note 8 - Convertible Notes Pa54
Note 8 - Convertible Notes Payable - Convertible Debt (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2016 | Dec. 31, 2015 | Mar. 18, 2013 | |
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | ||
Debt Instrument, Face Amount | $ 7,050,000 | $ 7,275,000 | |
Convertible Notes Payable | 0 | 0 | |
Convertible notes payable, current portion | 50,000 | 75,000 | |
Convertible notes payable, related parties, long term, net of current portion | 5,825,000 | 5,850,000 | |
Non-Related Party [Member] | |||
Convertible notes payable, current portion | 50,000 | 75,000 | |
Convertible notes payable, related parties, long term, net of current portion | 1,175,000 | 1,350,000 | |
Related Party [Member] | |||
Convertible notes payable, current portion | $ 5,825,000 | $ 5,850,000 | |
Convertible Note Payable 10% $862,500 [Member] | |||
Maturity date | Jun. 30, 2004 | Jun. 30, 2004 | |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | 10.00% | |
Debt Instrument, Face Amount | $ 50,000 | $ 75,000 | |
Convertible Notes Payable | 0 | 0 | |
Convertible Note Payable 10% $862,500 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 50,000 | 75,000 | |
Convertible notes payable, related parties, long term, net of current portion | 0 | 0 | |
Convertible Note Payable 10% $862,500 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 0 | $ 0 | |
Convertible Notes Payable 10% $150,000 [Member] | |||
Maturity date | Apr. 1, 2018 | Apr. 1, 2017 | |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | 10.00% | |
Debt Instrument, Face Amount | $ 150,000 | $ 150,000 | |
Convertible Notes Payable | 0 | 0 | |
Convertible Notes Payable 10% $150,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | 0 | |
Convertible notes payable, related parties, long term, net of current portion | 150,000 | 150,000 | |
Convertible Notes Payable 10% $150,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 0 | $ 0 | |
Convertible Notes Payable 10% $2,120,000 [Member] | |||
Maturity date | Apr. 1, 2020 | Apr. 1, 2017 | |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | 10.00% | |
Debt Instrument, Face Amount | $ 1,770,000 | $ 1,770,000 | |
Convertible Notes Payable | 0 | 0 | |
Convertible Notes Payable 10% $2,120,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | 0 | |
Convertible notes payable, related parties, long term, net of current portion | 0 | 0 | |
Convertible Notes Payable 10% $2,120,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 1,770,000 | $ 1,770,000 | |
Convertible Notes Payable 12 Percent 375,000 [Member] | |||
Maturity date | Apr. 1, 2018 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Debt Instrument, Face Amount | $ 200,000 | ||
Convertible Notes Payable | 0 | ||
Convertible Notes Payable 12 Percent 375,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | ||
Convertible notes payable, related parties, long term, net of current portion | 200,000 | ||
Convertible Notes Payable 12 Percent 375,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 0 | ||
Convertible Notes Payable 12 Percent 260,000 [Member] | |||
Maturity date | Apr. 1, 2017 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Debt Instrument, Face Amount | $ 260,000 | ||
Convertible Notes Payable | 0 | ||
Convertible Notes Payable 12 Percent 260,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | ||
Convertible notes payable, related parties, long term, net of current portion | 260,000 | ||
Convertible Notes Payable 12 Percent 260,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 0 | ||
Convertible Notes Payable12 Percent,100,000 [Member] | |||
Maturity date | Apr. 1, 2020 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Debt Instrument, Face Amount | $ 100,000 | ||
Convertible Notes Payable | 0 | ||
Convertible Notes Payable12 Percent,100,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | ||
Convertible notes payable, related parties, long term, net of current portion | 100,000 | ||
Convertible Notes Payable12 Percent,100,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 0 | ||
Convertible Notes Payable, 12%, $4,570,000 [Member] | |||
Maturity date | Apr. 1, 2020 | Apr. 1, 2017 | |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | |
Debt Instrument, Face Amount | $ 4,055,000 | $ 4,055,000 | |
Convertible Notes Payable | 0 | 0 | |
Convertible Notes Payable, 12%, $4,570,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | 0 | |
Convertible notes payable, related parties, long term, net of current portion | 0 | 0 | |
Convertible Notes Payable, 12%, $4,570,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 4,055,000 | $ 4,055,000 | |
Convertible Notes Payable, 12%, $215,000 [Member] | |||
Maturity date | Apr. 1, 2018 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Debt Instrument, Face Amount | $ 215,000 | ||
Convertible Notes Payable | 0 | ||
Convertible Notes Payable, 12%, $215,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | ||
Convertible notes payable, related parties, long term, net of current portion | 215,000 | ||
Convertible Notes Payable, 12%, $215,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 0 | ||
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member] | |||
Maturity date | Apr. 1, 2018 | Apr. 1, 2018 | |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | |
Debt Instrument, Face Amount | $ 100,000 | $ 100,000 | |
Convertible Notes Payable | 0 | 0 | |
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | 0 | |
Convertible notes payable, related parties, long term, net of current portion | 100,000 | 100,000 | |
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 0 | $ 0 | |
Convertible Notes Payable, 12%, $25,000 [Member] | |||
Maturity date | Apr. 1, 2018 | ||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||
Debt Instrument, Face Amount | $ 25,000 | ||
Convertible Notes Payable | 0 | ||
Convertible Notes Payable, 12%, $25,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | ||
Convertible notes payable, related parties, long term, net of current portion | 0 | ||
Convertible Notes Payable, 12%, $25,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 25,000 | ||
Convertible Notes Payable 12% 1,300,000 [Member] | |||
Maturity date | Apr. 1, 2020 | Apr. 1, 2017 | |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | |
Debt Instrument, Face Amount | $ 625,000 | $ 625,000 | |
Convertible Notes Payable | 0 | 0 | |
Convertible Notes Payable 12% 1,300,000 [Member] | Non-Related Party [Member] | |||
Convertible notes payable, current portion | 0 | 0 | |
Convertible notes payable, related parties, long term, net of current portion | 625,000 | 625,000 | |
Convertible Notes Payable 12% 1,300,000 [Member] | Related Party [Member] | |||
Convertible notes payable, current portion | $ 0 | $ 0 |
Note 8 - Convertible Notes Pa55
Note 8 - Convertible Notes Payable - Convertible Debt Maturity Payments (Details) - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
Total | $ 0 | $ 0 |
Convertible Debt [Member] | ||
2,017 | 50,000 | |
2,018 | 450,000 | |
2,019 | 0 | |
2,020 | 6,550,000 | |
Total | $ 7,050,000 |
Note 9 - Fair Value Measureme56
Note 9 - Fair Value Measurement (Details Textual) | 12 Months Ended |
Dec. 31, 2016 | |
Minimum [Member] | |
Finite-Lived Intangible Asset, Useful Life | 3 years |
Maximum [Member] | |
Finite-Lived Intangible Asset, Useful Life | 15 years |
Note 9 - Fair Value Measureme57
Note 9 - Fair Value Measurement - Fair Value of Liabilities Measured on a Recurring Basis (Details) - USD ($) | Dec. 31, 2016 | [2] | Dec. 31, 2015 | [3] | |
Derivative Liability fair value | [1] | $ 6,325,092 | $ 2,816,166 | ||
Fair Value, Inputs, Level 1 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Fair Value, Inputs, Level 2 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | |||||
Derivative Liability fair value | [1] | 6,325,092 | 2,816,166 | ||
Conversion Feature Liability [Member] | |||||
Derivative Liability fair value | [1] | 2,325,730 | 901,243 | ||
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 1 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 2 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 3 [Member] | |||||
Derivative Liability fair value | [1] | 2,325,730 | 901,243 | ||
Warrant Liability [Member] | |||||
Derivative Liability fair value | [1] | 3,999,362 | 1,914,923 | ||
Warrant Liability [Member] | Fair Value, Inputs, Level 1 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Warrant Liability [Member] | Fair Value, Inputs, Level 2 [Member] | |||||
Derivative Liability fair value | [1] | 0 | 0 | ||
Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member] | |||||
Derivative Liability fair value | [1] | $ 3,999,362 | $ 1,914,923 | ||
[1] | The fair value at the measurement date is equal to the carrying value on the balance sheet | ||||
[2] | The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2016 | ||||
[3] | The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2015 |
Note 9 - Fair Value Measureme58
Note 9 - Fair Value Measurement - Fair Value Assumptions (Details) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Dividend yield | 0.00% | 0.00% |
Minimum [Member] | ||
Risk free interest rate | 0.82% | 0.48% |
Expected volatility | 117.30% | 91.00% |
Minimum [Member] | Conversion Feature Liability [Member] | ||
Expected life (Year) | 1 year 91 days | 1 year 91 days |
Minimum [Member] | Warrant Liability [Member] | ||
Expected life (Year) | 91 days | 0 years |
Maximum [Member] | ||
Risk free interest rate | 1.45% | 1.20% |
Expected volatility | 143.80% | 132.20% |
Maximum [Member] | Conversion Feature Liability [Member] | ||
Expected life (Year) | 3 years 91 days | 2 years 91 days |
Maximum [Member] | Warrant Liability [Member] | ||
Expected life (Year) | 3 years 91 days | 3 years 3 days |
Note 9 - Fair Value Measureme59
Note 9 - Fair Value Measurement - Fair Value of Assets Acquired on Non-recurring Basis (Details) - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | |
Promasys B.V. customer list | [1],[2] | $ 82,173 | $ 92,444 | $ 110,948 |
Promasys B.V. software code | [1],[2] | 26,707 | 41,274 | 55,842 |
Promasys B.V. URLs/website | [1],[2] | 0 | 15,159 | 37,131 |
Total | [2] | 108,880 | 148,877 | $ 203,921 |
Fair Value, Inputs, Level 1 [Member] | ||||
Promasys B.V. customer list | [1],[2] | 0 | 0 | |
Promasys B.V. software code | [1],[2] | 0 | 0 | |
Promasys B.V. URLs/website | [1],[2] | 0 | 0 | |
Total | [2] | 0 | 0 | |
Fair Value, Inputs, Level 2 [Member] | ||||
Promasys B.V. customer list | [1],[2] | 0 | 0 | |
Promasys B.V. software code | [1],[2] | 0 | 0 | |
Promasys B.V. URLs/website | [1],[2] | 0 | 0 | |
Total | [2] | 0 | 0 | |
Fair Value, Inputs, Level 3 [Member] | ||||
Promasys B.V. customer list | [1],[2] | 136,253 | 136,253 | |
Promasys B.V. software code | [1],[2] | 72,943 | 72,943 | |
Promasys B.V. URLs/website | [1],[2] | 68,814 | 68,814 | |
Total | [2] | $ 278,010 | $ 278,010 | |
[1] | The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction. | |||
[2] | The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied. |
Note 9 - Fair Value Measureme60
Note 9 - Fair Value Measurement - Unrealized Gain or Loss Included in Earnings (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
The net amount of gains/(losses) for the period included in earnings attributable to the unrealized and realized gains/(losses) from changes in derivative liabilities at the reporting date | $ (2,657,910) | $ 4,525,798 |
Total unrealized and realized gains/(losses) included in earnings | $ (2,657,910) | $ 4,525,798 |
Note 9 - Fair Value Measureme61
Note 9 - Fair Value Measurement - Change in Level 3 Financial Liabilities Fair Value (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Balance beginning of year | $ (2,816,166) | $ (9,639,462) |
Net realized gains/(losses) | 29,108 | 29,875 |
Net unrealized gains/(losses) relating to instruments still held at the reporting date | (2,687,018) | 4,495,923 |
Net purchases, issuances and settlements | (851,016) | (868,128) |
Net transfers in and/or out of Level 3 | 0 | 3,165,626 |
Balance, end of period | (6,325,092) | (2,816,166) |
Conversion Feature Liability [Member] | ||
Balance beginning of year | (901,243) | (2,944,402) |
Net realized gains/(losses) | 29,108 | 29,875 |
Net unrealized gains/(losses) relating to instruments still held at the reporting date | (1,453,595) | 2,013,284 |
Net purchases, issuances and settlements | 0 | 0 |
Net transfers in and/or out of Level 3 | 0 | 0 |
Balance, end of period | (2,325,730) | (901,243) |
Warrant Liability [Member] | ||
Balance beginning of year | (1,914,923) | (6,695,060) |
Net realized gains/(losses) | 0 | 0 |
Net unrealized gains/(losses) relating to instruments still held at the reporting date | (1,233,423) | 2,482,639 |
Net purchases, issuances and settlements | (851,016) | (868,128) |
Net transfers in and/or out of Level 3 | 0 | 3,165,626 |
Balance, end of period | $ (3,999,362) | $ (1,914,923) |
Note 10 - Commitments and Con62
Note 10 - Commitments and Contingencies (Details Textual) | 1 Months Ended | 12 Months Ended | |
Jun. 30, 2009USD ($) | Dec. 31, 2016USD ($)$ / sharesshares | Dec. 31, 2015USD ($)$ / shares | |
Operating Leases, Rent Expense | $ 1,071,363 | $ 972,862 | |
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | |||
License Payments | $ 300,000 | ||
Other Expenses | $ 94,129 | $ 244,747 | |
Loss Contingency, Pending Claims, Number | 0 | ||
Settlement and Licensing Agreement [Member] | |||
Patent Royalty Percentage Obligation | 2.00% | ||
Anticipated Annual Royalty Payments | $ 450,000 | ||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 1,000,000 | ||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.01 | ||
Loss Contingency, Estimate of Possible Loss | $ 300,000 |
Note 10 - Commitments and Con63
Note 10 - Commitments and Contingencies - Minimum Royalty Payments Per Year (Details) | Dec. 31, 2016USD ($) |
2,017 | $ 655,832 |
2,018 | 512,157 |
2,019 | 421,230 |
2,020 | 297,570 |
2,021 | 269,962 |
Thereafter | 310,550 |
Total | $ 2,467,301 |
Note 10 - Commitments and Con64
Note 10 - Commitments and Contingencies - Future Minimum Lease Payments (Details) | Dec. 31, 2016USD ($) |
2,017 | $ 450,000 |
2,018 | 164,500 |
Total | $ 614,500 |
Note 11 - Related Party Trans65
Note 11 - Related Party Transactions (Details Textual) | Nov. 19, 2015USD ($)$ / sharesshares | May 01, 2015USD ($) | Jan. 31, 2015USD ($)$ / sharesshares | Jan. 01, 2014USD ($)$ / sharesshares | Mar. 18, 2013USD ($) | Dec. 31, 2009USD ($)shares | Dec. 16, 2008USD ($)$ / sharesshares | Sep. 30, 2009USD ($)$ / sharesshares | Aug. 29, 2008USD ($)$ / sharesshares | Dec. 31, 2016USD ($)$ / shares | Dec. 31, 2015USD ($)$ / sharesshares | Jun. 30, 2016USD ($) | Feb. 29, 2016USD ($)$ / sharesshares | Nov. 23, 2015USD ($) | Oct. 15, 2015USD ($) | Apr. 30, 2015USD ($) | Apr. 01, 2015USD ($) | Feb. 03, 2015USD ($) | Dec. 18, 2013USD ($) | Feb. 22, 2013USD ($) | Oct. 16, 2012USD ($)shares | Jun. 30, 2008USD ($) | Feb. 29, 2008USD ($) |
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | ||||||||||||||||||||||
Convertible Notes Payable | $ 0 | $ 0 | |||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 0 | $ 1,915,000 | |||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | shares | 29,363,517 | ||||||||||||||||||||||
Debt Instrument, Convertible, Number of Equity Instruments | 15,490,000 | ||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | |||||||||||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,000,000 | $ 5,000,000 | $ 4,000,000 | ||||||||||||||||||||
Long-term Line of Credit | $ 2,700,000 | ||||||||||||||||||||||
Line of Credit Facility, Interest Rate at Period End | 2.75% | ||||||||||||||||||||||
Interest Expense, Related Party | $ 918,189 | $ 2,434,101 | |||||||||||||||||||||
The Northern Trust Company [Member] | |||||||||||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 2,000,000 | $ 5,000,000 | $ 4,000,000 | ||||||||||||||||||||
Line of Credit Facility, Interest Rate During Period | 2.00% | ||||||||||||||||||||||
Long-term Line of Credit | $ 2,700,000 | ||||||||||||||||||||||
Line of Credit Facility, Interest Rate at Period End | 2.75% | ||||||||||||||||||||||
Director Mr. Wit [Member] | |||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | shares | 1,900,000 | ||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.25 | ||||||||||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | shares | 37,023,517 | ||||||||||||||||||||||
Warrants Cancelled | shares | 29,363,517 | ||||||||||||||||||||||
Interest Expense, Related Party Approximately Monthly Amount | $ 9,500 | ||||||||||||||||||||||
Chief Executive Officer [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 450,000 | ||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 1,800,000 | ||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.25 | ||||||||||||||||||||||
Interest Payable | $ 450,000 | ||||||||||||||||||||||
12% Promissory Notes [Member] | Chairman and Chief Technology Officer [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Matures On April 1, 2017 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | shares | 11,440,000 | ||||||||||||||||||||||
12% Promissory Notes [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 6,919,000 | ||||||||||||||||||||||
12% Promissory Notes [Member] | Chairman and Chief Technology Officer [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 20,000 | ||||||||||||||||||||||
Convertible Debentures [Member] | Chief Operating Officer [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Convertible Notes Payable | $ 25,000 | ||||||||||||||||||||||
Convertible Debentures [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Convertible Notes Payable | $ 510,000 | ||||||||||||||||||||||
Due to Related Parties | $ 5,825,000 | ||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 510,000 | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 5,760,000 | ||||||||||||||||||||||
Convertible Debentures [Member] | Chairman and Chief Technology Officer [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Related Party Transaction, Amounts of Transaction | $ 5,000 | ||||||||||||||||||||||
Promissory Notes [Member] | CEO And Director [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 450,000 | ||||||||||||||||||||||
Convertible Debenture Initiated In June 2008 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||||||||||||||
Convertible Notes Payable | $ 1,770,000 | $ 1,770,000 | $ 1,260,000 | $ 1,770,000 | $ 1,770,000 | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 3,540,000 | ||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.50 | ||||||||||||||||||||||
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 150,000 | ||||||||||||||||||||||
Convertible Notes Payable | 4,475,000 | $ 4,350,000 | $ 4,475,000 | $ 125,000 | $ 4,200,000 | ||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 4,350,000 | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 1,680,000 | 8,700,000 | 250,000 | ||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.50 | ||||||||||||||||||||||
Debt Conversion, Converted Instrument, Rate | 12.00% | ||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 420,000 | ||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | shares | 1,680,000 | ||||||||||||||||||||||
Convertible Debenture Initiated In February 2008 [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member] | |||||||||||||||||||||||
Convertible Notes Payable | $ 4,055,000 | ||||||||||||||||||||||
Aggregated Convertible Debt July - September 30, 2009 [Member] | |||||||||||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | shares | 1,900,000 | ||||||||||||||||||||||
Aggregated Convertible Debt July - September 30, 2009 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Convertible Notes Payable | 1,100,000 | $ 1,100,000 | |||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 475,000 | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 1,900,000 | 4,400,000 | |||||||||||||||||||||
Extinguishment of Debt, Amount | $ 475,000 | ||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | shares | 1,900,000 | ||||||||||||||||||||||
Debt Instrument, Convertible, Number of Equity Instruments | 4,400,000 | ||||||||||||||||||||||
Warrants and Rights Outstanding | $ 4,400,000 | ||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.25 | ||||||||||||||||||||||
Warrants Extension of Maturity | 2 years | ||||||||||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | shares | 5,760,000 | ||||||||||||||||||||||
Notes Payable Related Parties Amount Transfered | $ 625,000 | ||||||||||||||||||||||
Aggregated Convertible Debt October - December 31, 2009 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Convertible Notes Payable | 1,440,000 | $ 1,440,000 | |||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 1,440,000 | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 5,760,000 | ||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 1,440,000 | ||||||||||||||||||||||
Class of Warrant or Right Cancelled During the Period | shares | 5,760,000 | ||||||||||||||||||||||
Warrants Extension of Maturity | 2 years | ||||||||||||||||||||||
Matures On April 1, 2017 [Member] | Accrued Interest [Member] | |||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 980,000 | ||||||||||||||||||||||
Matures On April 1, 2017 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | 2,860,000 | $ 980,000 | $ 980,000 | ||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | 12.00% | |||||||||||||||||||||
Related Party Transaction, Amounts of Transaction | 6,879 | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 3,920,000 | ||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.25 | ||||||||||||||||||||||
Stock Issued During Period Converted Cancelled Debt and Cancelled Warrants Shares | shares | 11,440,000 | ||||||||||||||||||||||
Matures on January 1, 2019 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 3,920,000 | ||||||||||||||||||||||
Matures on April 1, 2019 [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 2,860,000 | ||||||||||||||||||||||
Matures On April 1, 2017 II [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 529,000 | ||||||||||||||||||||||
Matures On April 1, 2017 II [Member] | Director Mr. Wit [Member] | Notes Payable, Other Payables [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Matures On January 1, 2019 II [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 529,000 | ||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 2,116,000 | ||||||||||||||||||||||
Matures On April 1, 2017 III [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 950,000 | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 3,800,000 | ||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 280,000 | ||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 0.25 | ||||||||||||||||||||||
Matures On April 1, 2017 III [Member] | Director Mr. Wit [Member] | Accrued Interest [Member] | |||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 670,000 | ||||||||||||||||||||||
Matures On January 1, 2019 IV [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Notes Payable, Related Parties | $ 950,000 | ||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 3,800,000 | ||||||||||||||||||||||
Matures On January 1, 2019 III [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
12% Percent Convertible Notes Payable [Member] | Director Mr. Wit [Member] | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | ||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 1,915,000 | ||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.25 | ||||||||||||||||||||||
Extinguishment of Debt, Amount | $ 420,000 |
Note 12 - Stockholders' (Defi66
Note 12 - Stockholders' (Deficit) (Details Textual) | Dec. 30, 2016shares | Jul. 20, 2016shares | Jun. 16, 2016shares | Apr. 26, 2016shares | Apr. 25, 2016shares | Apr. 13, 2016shares | Dec. 31, 2015$ / sharesshares | Nov. 19, 2015USD ($)$ / sharesshares | Oct. 16, 2015shares | Aug. 21, 2015shares | Jul. 17, 2015shares | Jun. 30, 2015shares | Jun. 15, 2015shares | Jun. 11, 2015shares | Apr. 29, 2015shares | Mar. 23, 2015shares | Mar. 20, 2015shares | Dec. 31, 2015$ / sharesshares | Apr. 30, 2016shares | Dec. 31, 2016USD ($)$ / sharesshares | Dec. 31, 2015USD ($)$ / sharesshares | Dec. 31, 1999shares | Dec. 31, 2014shares | Dec. 31, 2016USD ($)$ / sharesshares | Dec. 31, 2016USD ($)$ / sharesshares | Mar. 18, 2013 | Nov. 30, 2010shares | Mar. 31, 2002shares | Feb. 07, 2002shares | Aug. 31, 2001shares |
Common Stock, Shares Authorized | 500,000,000 | 500,000,000 | 500,000,000 | 500,000,000 | 500,000,000 | 500,000,000 | ||||||||||||||||||||||||
Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | ||||||||||||||||||||||||
Common Stock, Shares, Issued | 131,703,577 | 131,703,577 | 147,786,917 | 131,703,577 | 147,786,917 | 147,786,917 | ||||||||||||||||||||||||
Class of Warrant or Right, Issued | 27,860,000 | 27,860,000 | 27,860,000 | |||||||||||||||||||||||||||
Convertible Debt | $ | $ 7,050,000 | $ 7,050,000 | $ 7,050,000 | |||||||||||||||||||||||||||
Debt Instrument, Convertible, Number of Equity Instruments | 15,490,000 | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 1,120,000 | 292,500 | ||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | |||||||||||||||||||||||||||||
Preferred Stock, Amount of Preferred Dividends in Arrears | $ | $ 2,081,980 | $ 4,547,810 | ||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||
Common Stock, Shares, Outstanding | 131,703,577 | 131,703,577 | 147,786,917 | 131,703,577 | 147,786,917 | 147,786,917 | ||||||||||||||||||||||||
Class of Warrant or Right, Outstanding | 22,900,000 | 22,900,000 | 27,860,000 | 22,900,000 | 48,463,517 | 27,860,000 | 27,860,000 | |||||||||||||||||||||||
Conversion of Series A Preferred Stock into Common Shares [Member] | ||||||||||||||||||||||||||||||
Conversion of Stock, Shares Converted | 487,500 | 3,637,724 | ||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 1,950,000 | 14,615,696 | ||||||||||||||||||||||||||||
Common Stock [Member] | ||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 1,100,000 | 252,500 | ||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 14,615,696 | 1,950,000 | ||||||||||||||||||||||||||||
Employee [Member] | ||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 3,038 | 1,594 | 1,000,000 | 3,012 | ||||||||||||||||||||||||||
Chief Executive Officer [Member] | ||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ | $ 1,915,000 | |||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 0.25 | |||||||||||||||||||||||||||||
Chief Executive Officer [Member] | 12% Promissory Notes [Member] | ||||||||||||||||||||||||||||||
Extinguishment of Debt, Amount | $ | $ 6,919,000 | |||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||
Chief Executive Officer [Member] | 12% Percent Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||
Extinguishment of Debt, Amount | $ | $ 420,000 | |||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||||||||||||||||||||||||||
Chief Executive Officer [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross | 37,023,517 | |||||||||||||||||||||||||||||
Warrants Cancelled | 29,363,517 | |||||||||||||||||||||||||||||
Warrants Cancelled, Price Per Share of Common Stock | $ / shares | $ 0.25 | |||||||||||||||||||||||||||||
Chief Financial Officer [Member] | ||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 100,000 | |||||||||||||||||||||||||||||
Restricted Stock [Member] | Former Employee [Member] | ||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 50,002 | 66,668 | ||||||||||||||||||||||||||||
Employee Stock Option [Member] | Former Employee [Member] | ||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 7,500 | |||||||||||||||||||||||||||||
Employee Stock Option [Member] | Employee [Member] | ||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 1,628 | 20,000 | 225,000 | 5,800 | ||||||||||||||||||||||||||
Equity Incentive Plan 2009 [Member] | ||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 5 years | |||||||||||||||||||||||||||||
Equity Incentive Plan 2009 [Member] | Director [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross | 360,000 | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 3 years | |||||||||||||||||||||||||||||
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member] | Senior Management Team [Member] | ||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross | 665,000 | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 3 years | |||||||||||||||||||||||||||||
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member] | Board of Directors Chairman [Member] | ||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross | 360,000 | |||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 3 years | |||||||||||||||||||||||||||||
Series A Preferred Stock [Member] | ||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | |||||||||||||||||||||||
Preferred Stock, Dividend Rate, Percentage | 5.00% | 5.00% | 5.00% | 5.00% | ||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding | 3,637,724 | 3,637,724 | 0 | 3,637,724 | 0 | 0 | ||||||||||||||||||||||||
Conversion of Stock, Shares Converted | 235,000 | |||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | (3,637,724) | (487,500) | ||||||||||||||||||||||||||||
Convertible Preferred Stock, Conversion Price | $ / shares | $ 1.11 | |||||||||||||||||||||||||||||
Convertible Preferred Stock, Conversion Term | 1 year | |||||||||||||||||||||||||||||
Convertible Preferred Stock, Stock Price Trigger | $ / shares | $ 3 | |||||||||||||||||||||||||||||
Convertible Preferred Stock, Threshold Consecutive Trading Days | 20 days | |||||||||||||||||||||||||||||
Preferred Stock, Redemption Price Per Share | $ / shares | $ 1 | $ 1 | $ 1 | |||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share | $ / shares | $ 1 | 1 | 1 | |||||||||||||||||||||||||||
Voting Rights, Number of Votes | 1 | |||||||||||||||||||||||||||||
Preferred Stock, Amount of Preferred Dividends in Arrears | $ | $ 0 | $ 2,465,830 | ||||||||||||||||||||||||||||
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares | $ 0 | $ 0.68 | ||||||||||||||||||||||||||||
Number of Shareholders, Exchange Offer Initiated | 34 | |||||||||||||||||||||||||||||
Convertible Preferred Stock, Shares Issued upon Conversion | 4 | 4 | 4 | |||||||||||||||||||||||||||
Number of Shareholders, Exchange Offer Accepted | 4 | |||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||
Preferred Stock, Shares Issued | 3,637,724 | 3,637,724 | 0 | 3,637,724 | 0 | 0 | ||||||||||||||||||||||||
Series B Preferred Stock [Member] | ||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 200,000 | ||||||||||||||||||||||
Preferred Stock, Dividend Rate, Percentage | 8.00% | |||||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
Conversion of Stock, Shares Converted | 200,000 | |||||||||||||||||||||||||||||
Convertible Preferred Stock, Stock Price Trigger | $ / shares | $ 0.50 | |||||||||||||||||||||||||||||
Convertible Preferred Stock, Threshold Consecutive Trading Days | 20 years | |||||||||||||||||||||||||||||
Preferred Stock, Redemption Price Per Share | $ / shares | $ 10 | $ 10 | $ 10 | |||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share | $ / shares | $ 10 | 10 | 10 | |||||||||||||||||||||||||||
Voting Rights, Number of Votes | 1 | |||||||||||||||||||||||||||||
Preferred Stock, Amount of Preferred Dividends in Arrears | $ | $ 609,887 | $ 609,887 | ||||||||||||||||||||||||||||
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares | $ 3.05 | $ 3.05 | ||||||||||||||||||||||||||||
Share Price | $ / shares | $ 0.25 | 0.25 | 0.25 | |||||||||||||||||||||||||||
Convertible Preferred Stock, Public Offering Proceeds Threshold | $ | $ 25,000,000 | |||||||||||||||||||||||||||||
Voting Rights, Number of Members of Board of Congress | 1 | |||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||
Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
Series C Preferred Stock [Member] | ||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized | 747,500 | 747,500 | 747,500 | 747,500 | 747,500 | 747,500 | 747,500 | |||||||||||||||||||||||
Preferred Stock, Dividend Rate, Percentage | 8.00% | |||||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
Conversion of Stock, Shares Converted | 337,150 | |||||||||||||||||||||||||||||
Convertible Preferred Stock, Threshold Consecutive Trading Days | 20 days | |||||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share | $ / shares | $ 10 | $ 10 | $ 10 | |||||||||||||||||||||||||||
Voting Rights, Number of Votes | 1 | |||||||||||||||||||||||||||||
Preferred Stock, Amount of Preferred Dividends in Arrears | $ | $ 1,472,093 | $ 1,472,093 | ||||||||||||||||||||||||||||
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ / shares | $ 4.37 | $ 4.37 | ||||||||||||||||||||||||||||
Share Price | $ / shares | $ 0.25 | 0.25 | 0.25 | |||||||||||||||||||||||||||
Convertible Preferred Stock, Public Offering Proceeds Threshold | $ | $ 25,000,000 | |||||||||||||||||||||||||||||
Voting Rights, Number of Members of Board of Congress | 2 | |||||||||||||||||||||||||||||
Convertible Preferred Stock, Offering Price Threshold Ratio | 2.5 | |||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||
Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
Series D Preferred Stock [Member] | ||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | |||||||||||||||||||||||
Preferred Stock, Shares Outstanding | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | ||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||
Voting Rights, Number of Votes | 400 | |||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||
Preferred Stock, Right of First Refusal | 30 days | |||||||||||||||||||||||||||||
Preferred Stock, Shares Issued | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | ||||||||||||||||||||||||
Convertible Series B Preferred Stock [Member] | ||||||||||||||||||||||||||||||
Share Price | $ / shares | $ 0.75 | $ 0.75 | $ 0.75 |
Note 12 - Stockholders' (Defi67
Note 12 - Stockholders' (Deficit) - Cumulative Arrearage of Undeclared Dividends (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Preferred Stock, Amount of Preferred Dividends in Arrears | $ 2,081,980 | $ 4,547,810 |
Series A Preferred Stock [Member] | ||
Preferred Stock, Amount of Preferred Dividends in Arrears | $ 0 | $ 2,465,830 |
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ 0 | $ 0.68 |
Series B Preferred Stock [Member] | ||
Preferred Stock, Amount of Preferred Dividends in Arrears | $ 609,887 | $ 609,887 |
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ 3.05 | $ 3.05 |
Series C Preferred Stock [Member] | ||
Preferred Stock, Amount of Preferred Dividends in Arrears | $ 1,472,093 | $ 1,472,093 |
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears | $ 4.37 | $ 4.37 |
Note 12 - Stockholders' (Defi68
Note 12 - Stockholders' (Deficit) - Dividends Payable (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Series A Preferred Stock [Member] | ||
Dividends accreted | $ 0 | $ 181,886 |
Divideds accreted per share (in dollars per share) | $ 0 | $ 0.05 |
Series B Preferred Stock [Member] | ||
Dividends accreted | $ 0 | $ 0 |
Divideds accreted per share (in dollars per share) | $ 0 | $ 0 |
Series C Preferred Stock [Member] | ||
Dividends accreted | $ 0 | $ 0 |
Divideds accreted per share (in dollars per share) | $ 0 | $ 0 |
Note 12 - Stockholders' (Defi69
Note 12 - Stockholders' (Deficit) - Warrants (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | |
Class of Warrant or Right, Exercise Price of Warrants or Rights | |||
Class of Warrant or Right, Outstanding | 27,860,000 | 22,900,000 | 48,463,517 |
Weighted average remaining contractual life (Year) | 2 years 259 days | 1 year 277 days | |
Weighted average exercise price (in dollars per share) | $ 0.42 | $ 0.46 | |
Warrants exercisable at December 31, 2016 (in shares) | 27,860,000 | 22,900,000 | |
Warrants exercisable Weighted average exercise price (in dollars per share) | $ 0.42 | $ 0.46 | |
Minimum [Member] | |||
Class of Warrant or Right, Exercise Price of Warrants or Rights | 0.25 | 0.25 | |
Maximum [Member] | |||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.60 | $ 0.60 |
Note 12 - Stockholders' (Defi70
Note 12 - Stockholders' (Deficit) - Warrants Activity (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Balance (in shares) | 22,900,000 | 48,463,517 |
Issued (in shares) | 4,970,000 | 3,800,000 |
Exercised (in shares) | 0 | 0 |
Cancelled (in shares) | (29,363,517) | |
Expired/forfeited (in shares) | (10,000) | 0 |
Balance (in shares) | 27,860,000 | 22,900,000 |
Warrants exercisable at December 31, 2016 (in shares) | 27,860,000 | 22,900,000 |
Weighted average fair value of warrants granted during 2016 | $ 0.16 |
Note 12 - Stockholders' (Defi71
Note 12 - Stockholders' (Deficit) - Accumulated Other Comprehensive Gain (Loss) (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Balance | $ (21,418,474) | $ (35,774,832) |
Balance | (21,127,798) | (21,418,474) |
Accumulated Foreign Currency Adjustment Attributable to Parent [Member] | ||
Balance | (366,355) | (243,827) |
Activity | (44,150) | (122,528) |
Balance | (410,505) | (366,355) |
AOCI Attributable to Parent [Member] | ||
Balance | (366,355) | (243,827) |
Activity | (44,150) | (122,528) |
Balance | $ (410,505) | $ (366,355) |
Note 13 - Employee Equity Inc72
Note 13 - Employee Equity Incentive Plans (Details Textual) - USD ($) | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2016 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 1,225,000 | 2,002,500 | 3,130,000 | |
Proceeds from Stock Options Exercised | $ 129,500 | $ 27,250 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 0.19 | $ 0.24 | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $ 76,846 | |||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 2 years 138 days | |||
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense | $ 0 | $ 0 | ||
The 2016 Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 10,000,000 | |||
Common Stock Available for Issuance Increasing Period | 9 years | |||
Common Stock Available for Issuance, Annual Increase Percent | 5.00% | |||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 5 years | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 450,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 9,550,000 | |||
The 2016 Plan [Member] | Share-based Compensation Award, Tranche One [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 50.00% | |||
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 1 year | |||
The 2016 Plan [Member] | Share-based Compensation Award, Tranche Two [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 2 years | |||
The 2016 Plan [Member] | Employee Stock Option [Member] | ||||
Share-based Compensation Arrangement, Installments for Vesting | 2 | |||
The 2016 Plan [Member] | Restricted Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 0 | |||
The 2016 Plan [Member] | Maximum [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | |||
Equity Incentive Plan 2009 [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 7,500,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 5 years | |||
Share-based Compensation Arrangement, Installments for Vesting | 2 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 775,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 0 | |||
Equity Incentive Plan 2009 [Member] | Share-based Compensation Award, Tranche One [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 50.00% | |||
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 1 year | |||
Equity Incentive Plan 2009 [Member] | Share-based Compensation Award, Tranche Two [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 2 years | |||
Equity Incentive Plan 2009 [Member] | Restricted Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 3,893,330 | |||
Equity Incentive Plan 2009 [Member] | Maximum [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years |
Note 13 - Employee Equity Inc73
Note 13 - Employee Equity Incentive Plans - Stock Option Activity (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | |
Number of shares (in shares) | 2,002,500 | 3,130,000 | |
Weighted average exercise price (per share) (in dollars per share) | $ 0.14 | $ 0.20 | |
Weighted average remaining contractual term (in years) (Year) | 2 years 226 days | 1 year 146 days | 1 year 215 days |
Aggregate intrinsic value | $ 83,425 | $ 198,990 | $ 364,900 |
Number of shares, granted (in shares) | 450,000 | 225,000 | |
Weighted average exercise price (per share), granted (in dollars per share) | $ 0.20 | $ 0.25 | |
Number of shares, exercised (in shares) | (1,120,000) | (292,500) | |
Weighted average exercise price (per share), exercised (in dollars per share) | $ 0.12 | $ 0.12 | |
Number of shares, forfeited/cancelled/expired (in shares) | (107,500) | (1,060,000) | |
Weighted average exercise price (per share), forfeited/cancelled/expired (in dollars per share) | $ 0.29 | $ 0.35 | |
Number of shares (in shares) | 1,225,000 | 2,002,500 | 3,130,000 |
Weighted average exercise price (per share) (in dollars per share) | $ 0.17 | $ 0.14 | $ 0.20 |
Vested and exercisable at December 31, 2016 (in shares) | 737,500 | ||
Vested and exercisable at December 31, 2016 (in dollars per share) | $ 0.15 | ||
Vested and exercisable at December 31, 2016 (Year) | 1 year 138 days | ||
Vested and exercisable at December 31, 2016 | $ 64,550 |
Note 13 - Employee Equity Inc74
Note 13 - Employee Equity Incentive Plans - Vested Shares (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Number of options vested (in shares) | 162,500 | 200,000 |
Fair value of options vested | $ 33,622 | $ 34,665 |
Note 13 - Employee Equity Inc75
Note 13 - Employee Equity Incentive Plans - Stock Options Outstanding (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Low Price range (in dollars per share) | $ 0 | $ 0 |
High Price range (in dollars per share) | $ 0.70 | $ 0.70 |
Outstanding stock options (in shares) | 1,225,000 | 2,002,500 |
Weighted average remaining contractual life - outstanding (Year) | 2 years 226 days | 1 year 146 days |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0.17 | $ 0.14 |
Vested stock options (in shares) | 737,500 | 1,752,500 |
Weighted average remaining contractual life - vested (Year) | 1 year 138 days | 1 year 7 days |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0.15 | $ 0.13 |
Range One [Member] | ||
Low Price range (in dollars per share) | 0 | 0 |
High Price range (in dollars per share) | $ 0.20 | $ 0.20 |
Outstanding stock options (in shares) | 850,000 | 1,777,500 |
Weighted average remaining contractual life - outstanding (Year) | 2 years 54 days | 1 year 51 days |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0.15 | $ 0.13 |
Vested stock options (in shares) | 625,000 | 1,652,500 |
Weighted average remaining contractual life - vested (Year) | 1 year 116 days | 339 days |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0.14 | $ 0.13 |
Range Two [Member] | ||
Low Price range (in dollars per share) | 0.21 | 0.21 |
High Price range (in dollars per share) | $ 0.29 | $ 0.29 |
Outstanding stock options (in shares) | 375,000 | 125,000 |
Weighted average remaining contractual life - outstanding (Year) | 3 years 255 days | 2 years 302 days |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0.23 | $ 0.22 |
Vested stock options (in shares) | 112,500 | 100,000 |
Weighted average remaining contractual life - vested (Year) | 1 year 244 days | 2 years 167 days |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0.21 | $ 0.21 |
Range Three [Member] | ||
Low Price range (in dollars per share) | 0.30 | 0.30 |
High Price range (in dollars per share) | $ 0.49 | $ 0.49 |
Outstanding stock options (in shares) | 0 | 100,000 |
Weighted average remaining contractual life - outstanding (Year) | 0 years | 4 years 62 days |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0 | $ 0.30 |
Vested stock options (in shares) | 0 | 0 |
Weighted average remaining contractual life - vested (Year) | 0 years | 0 years |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0 | $ 0 |
Range Four [Member] | ||
Low Price range (in dollars per share) | 0.50 | 0.50 |
High Price range (in dollars per share) | $ 0.70 | $ 0.70 |
Outstanding stock options (in shares) | 0 | 0 |
Weighted average remaining contractual life - outstanding (Year) | 0 years | 0 years |
Weighted average outstanding strike price - outstanding (in dollars per share) | $ 0 | $ 0 |
Vested stock options (in shares) | 0 | 0 |
Weighted average remaining contractual life - vested (Year) | 0 years | 0 years |
Weighted average outstanding strike price - vested (in dollars per share) | $ 0 | $ 0 |
Note 13 - Employee Equity Inc76
Note 13 - Employee Equity Incentive Plans - Fair Value Assumptions of Share-based Payments (Details) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Risk-free interest rate | 1.45% | 1.20% |
Expected dividend yield | 0.00% | 0.00% |
Expected volatility | 155.50% | 183.80% |
Expected life of options (in years) (Year) | 5 years | 5 years |
Note 13 - Employee Equity Inc77
Note 13 - Employee Equity Incentive Plans - Weighted Average Grant Date Fair Value Activity (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Stock options granted during the period (in dollars per share) | $ 0.19 | $ 0.24 |
Stock options vested during the period (in dollars per share) | 0.21 | 0.17 |
Stock options forfeited during the period (in dollars per share) | $ 0.28 | $ 0.26 |
Note 13 - Employee Equity Inc78
Note 13 - Employee Equity Incentive Plans - Status of Non-vested Shares (Details) - $ / shares | Dec. 31, 2016 | Dec. 31, 2015 |
Shares underlying stock options (in shares) | 487,500 | 250,000 |
Weighted average grant date fair value (in dollars per share) | $ 0.20 | $ 0.23 |
Note 14 - Income Taxes (Details
Note 14 - Income Taxes (Details Textual) | 12 Months Ended |
Dec. 31, 2016USD ($) | |
Operating Loss Carryforwards | $ 35,363,091 |
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | $ (1,158,278) |
Note 14 - Income Taxes - Reconc
Note 14 - Income Taxes - Reconciliation of Income Tax Expense (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Federal statutory rate applied to income/(loss) before income taxes | $ 38,740 | $ 963,947 |
Increase/(decrease) in income taxes results from: | ||
Current tax expense/(benefit) | 1,069 | (24,739) |
Nondeductible expenses | 1,078,519 | (1,451,221) |
Change in deferred assets | 41,019 | 97,580 |
Change in valuation allowance | (1,158,278) | 389,694 |
Income tax expense/(benefit) | $ 1,069 | $ (24,739) |
Note 14 - Income Taxes - Compon
Note 14 - Income Taxes - Components of Income Tax Expense (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Current tax expense/(benefit) | $ 1,069 | $ (24,739) |
Deferred tax expense/(benefit) | 1,159,347 | (414,433) |
Change in valuation allowance | (1,158,278) | 389,694 |
Total tax expense/(benefit) | 1,069 | (24,739) |
Bad Debt Allowance [Member] | ||
Deferred tax expense/(benefit) | (23,699) | 26,059 |
Operating Loss Carryforward [Member] | ||
Deferred tax expense/(benefit) | 1,140,957 | (513,333) |
Amortization of Intangibles [Member] | ||
Deferred tax expense/(benefit) | 5,482 | 5,482 |
Patent Litigation Settlement [Member] | ||
Deferred tax expense/(benefit) | $ 35,538 | $ 92,098 |
Note 14 - Income Taxes - Deferr
Note 14 - Income Taxes - Deferred Income Taxes (Details) - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
Amortization of intangibles | $ 267,253 | $ 272,734 |
Bad debt allowance | 66,662 | 42,963 |
Patent litigation liability accrual | 128,804 | 164,342 |
Operating loss carryforwards | 19,034,573 | 20,175,531 |
Gross deferred tax assets | 19,497,292 | 20,655,570 |
Valuation allowance | (19,497,292) | (20,655,570) |
Net deferred tax liability/(asset) | $ 0 | $ 0 |
Note 15 - Subsequent Events (De
Note 15 - Subsequent Events (Details Textual) - USD ($) | Mar. 24, 2017 | Mar. 27, 2017 | Dec. 31, 2016 | Dec. 31, 2015 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 450,000 | 225,000 | ||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 0.20 | $ 0.25 | ||
Subsequent Event [Member] | ||||
Repayments of Lines of Credit | $ 400,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 500,000 | |||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 0.25 | |||
Subsequent Event [Member] | Restricted Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 16,668 |